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Abstract

Radiation therapy for cancer now includes several, significantly different techniques. To
ensure treatment quality, both in terms of safety and efficacy, each technique requires the
use of numerous, customized devices. This thesis considered two such devices, designed
at the Centre of Medical Radiation Physics, University of Wollongong, and investigated
their applications in scenarios that are particularly challenging in modern x-rays externalbeam radiation therapy.

The first device was a metal-oxide-semiconductor field-effect transistor (MOSFET)
named MOSkin. The MOSkin was first introduced to address the longstanding challenge
of measuring radiation dose to the skin of a patient. Other existing sensors were not able
to measure accurately in that context, and calculations with a treatment planning system
were known to be not adequate. In this thesis, the first step was to look into the MOSkin
seeking to optimize its design, so that it could be used to measure dose to the skin of a
patient who requires medical imaging with ionizing radiation. Examples of that imaging
include image-guided radiation therapy, but also a range of procedures used for diagnostic
radiology. The second step was to look into the MOSkin as a device to evaluate a novel
bolus. The bolus can be applied on the skin of a patient during x-rays radiation therapy,
to provide additional dose build-up and ensure high dose is delivered to the superficial
regions.

The second device was a two-dimensional monolithic array of silicon diodes named Octa.
The Octa was first introduced to address the challenge of measuring two-dimensional
dose distribution, with a spatio-temporal resolution commensurate with stereotactic xi

rays radiation therapy. Stereotactic treatments deliver radiation beams in arcs around the
patient so, in this thesis, the first step was to look into the sensitivity of the Octa changes
as a function of radiation’s angle of incidence. This investigation was also necessary to
prepare for the second step, which looked into the Octa as a quality assurance device in
the specific case of stereotactic body radiation therapy for vertebral metastases. The Octa
was considered a good candidate to map the two-dimensional distribution of radiation
dose across the vertebrae, and surrounding organs at risk such as the spinal cord,
demonstrating steep dose gradients were delivered to the patient as prescribed.

The present thesis demonstrated that (1) the MOSkin design can be optimized for
measuring dose to the skin of a patient who requires medical imaging that use ionizing
radiation and that (2)the MOSkin can be used to evaluate the suitability of novel bolus
for clinical use. Design optimization was achieved using sensitive volumes of a different
thickness. The present thesis also demonstrated that (3) the Octa sensitivity to radiation
is angularly dependent, but that this dependence can be characterized and accounted for,
and that (4) the Octa can be considered as a good candidate to ensure the quality of
stereotactic body radiation therapy for vertebral metastases.
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Chapter 1 - Introduction
1.1 Overview
According to the World Health Organisation (WHO), cancer is the second leading cause
for death globally, with the number of deaths about 9.6 million in 2018. At present, there
are three key modalities for treatment and palliative care, namely surgery, chemotherapy,
and radiation therapy. The main goal of treatment is to kill or remove the cancer and
improve the quality of life for patients. In radiation therapy, this can be achieved by
delivering the correct amount of radiation to the tumour, killing the cancer cells while
sparing healthy cells.
Modern radiation therapy uses a combination of small radiation fields to achieve high
conformity of dose placement. Treatments are performed with medical linear accelerators
(linacs). For these treatments, to satisfy the need for accurate quality assurance, a silicon
radiation sensor is often the dosimeter of choice. Silicon dosimeters are based on
generating of electron-hole pairs that are created when incident radiation beams pass
through a sensitive volume of silicon and deposit their energy. The amount of charge
carriers can be measured and is related to the dose deposited in the silicon. Silicon
dosimeters can be operated in passive mode (no external bias used), or in active mode,
and have sensitivities 1800 times greater than an ionization chambers of the same volume,
its cavity filled with air.
Currently, the diode is the most common silicon structure used for dosimetry. It is
fabricated on a silicon substrate, doped by adding boron (producing holes to create a ptype base) or phosphorous (as an electron donor to form n-type base), and then creating a
p-n junction. It is possible to fabricate small sensitive volumes while retaining high

1

sensitivity, fast signal collection and stable and linear response with accumulated dose
(Seco et al., 2014).
Recently, diode dosimeters have been used in radiation therapy to measure relative
absorbed dose and for verification of dose calculations with a treatment planning system.
Examples of such dosimeters includes the SFD diode (IBA Dosimetry, Germany) and the
MapCHEK3, a planar array of diodes (Sun Nuclear, USA).
There are limitations in using diode dosimeters in small radiation fields. For example,
their sensitivity to incident radiation varies as a function of instantaneous dose rate,
particles energy, angle of incidence.

1.2 Project aims and objectives.
In the present work, the candidate considered two silicon dosimeters designed at the
Centre of Medical Radiation Physics, University of Wollongong, and investigated their
potential for addressing the challenges of specific scenarios in modern x-rays externalbeam radiation therapy.
The first device was a metal-oxide-semiconductor field-effect transistor (MOSFET)
named MOSkin. After looking into the MOSkin seeking to optimize its design, so that it
could be used to measure radiation dose to the skin of a patient who requires medical
imaging that use ionizing radiation, the candidate looked into the MOSkin as a device to
evaluate a novel bolus called ‘eXaSkin’. Bolus can be applied on the skin of a patient
during radiation therapy, to provide additional dose build-up; this ensure high dose is
delivered to the tissue close to the skin.
The second device was a two-dimensional monolithic array of silicon diodes named Octa.
The dosimeter has 512 diodes overall, arranged along 4 arrays at 45 degrees with respect
to each other. After looking into the response of the Octa to incident radiation, and in
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particular into how that response changes as a function of the angle of incidence, the
candidate looked into the Octa as a quality assurance device in the case of stereotactic
body radiation therapy (SBRT) for vertebral metastases. This a particularly challenging
treatment that use many small radiation beams, shot from several different angles, as the
linac’s gantry rotates around the patient. The hypothesis was that the Octa is a good
candidate to map a two-dimensional distribution of radiation dose across the vertebrae,
and surrounding organs at risk such as the spinal cord, with a high spatial resolution (0.3
mm). These measurements could demonstrate the steep dose gradients, required to ensure
high dose to the vertebra but no dose to the spinal cord, are actually delivered to the
patient as prescribed.
This thesis consists of eight chapters. Chapter 1 includes the Introduction, the aims, and
the objectives of this thesis. Chapter 2 describes the current radiation therapy techniques,
and their quality assurance procedures, including dosimeters most commonly considered
in the context. The aims of this thesis are then achieved in the following chapters.
Part 1: the MOSkin, design improvements and applications.
Aim1: Optimizing the MOSkin for measurements of dose due to medical imaging.
Research question: is it possible to tune the sensitivity of the MOSkinTM and its lifespan for
measurements of radiation dose due to medical imaging?
This research question is addressed in more details in Chapter 3. Chapter 3 describes the
MOSkinTM as a dosimeter. It is operated in real-time with or without external bias and has
a very small sensitive volume. A MOSkin’s sensitivity to ionizing radiation can be adapted
to a certain application by fabricating the radiation-sensitive volume with a specific depth
or by modifying the external bias applied on its gate, during irradiation. However, an
improved sensitivity causes a decline in the MOSkin‘s lifespan. Chapter 3 then studies a
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way to increase sensitivity while decreasing lifespan decline. Various MOSkins were
used in this study with sensitive volumes of thickness 0.68 μm or 1.0 μm and various
concentration of boron implantation under the gate of silicon oxide. When irradiating the
MOSkins with a megavoltage medical linear accelerator (linac) and with orthovoltage xray tubes using various positive biases on the gate; a number of parameters were
evaluated, such as linearity with dose and sensitivity to photon beams.
Aim 2: Explore the characteristic of a novel eXaSkin bolus for radiation therapy
using the MOSkin.
Research question: does the novel eXaSkin bolus improve the dose delivered to the skin?
what are the differences in the build-up region using the eXaSkin bolus and water slabs?
What are the differences in the skin dose and in the central dose under the eXaSkin and
the alternative commercial Superflab bolus?
This research is addressed in chapter 4 where the characteristics of the novel eXaSkin
bolus, a high-density bolus alternative to the commercial tissue-equivalent Superflab,
were explored by two methods.
The first method evaluated the density of the eXaSkin bolus by shaping the bolus into
slabs and calculating the density as function of width, depth, length, and weight; then,
investigating the build-up dose characteristics of the eXaSkin for 6 MV photon beams,
using a Varian linac with a field size of 10 x 10cm2. The build-up dose characteristics of
eXaSkin with thickness 3, 5, 8, 10, 15 and 26 mm were investigated in comparison with
those of a solid water-equivalent slab of thickness 2, 5, 15, 20 and 26 mm. Additionally,
percentage surface dose measurements for various oblique incident beams with a 3 mm
thickness of eXaSkin bolus was also investigated. Measurements were performed using
a MOSkinTM dosimeter and cross-checked with an advanced Markus ionization chamber.
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The second method evaluated the eXaSkin for 6 MV radiation therapy clinical plans. The
density of the eXaSkin bolus was calculated with a computed tomography (CT) scan,
and a volumetric modulated arc radiation therapy (VMAT) head-and-neck plan was
delivered to an anthropomorphic phantom in three scenarios: with no bolus on the
phantom’s surface, with Superflab, and with eXaSkin. In each case, the dose to a central
planning target volume (PTV) in the nasopharynx region was measured with an ionization
chamber, and the dose to the skin, at three different positions within the vicinity of a neck
lymph node PTV, were measured with a MOSkinTM. Measurements were compared
against calculations with the treatment planning system (TPS).
Part 2: the Octa and its applications
Aim 3: In stereotactic therapy for vertebral metastases, a dosimeter should be able
to measure dose distribution in the horizontal plane, rather than the coronal plane
(Figure 1), is much needed. Aim 3 was to design a custom-made phantom to
accommodate the Octa dosimeter in the horizontal plane.
Research question: how to design a phantom suited to accommodate the Octa dosimeter
in the horizontal plane?

Figure 1. Schematic illustrating the (a) coronal plane (b) sagittal plane (c) horizontal planes.
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This research question is addressed in chapter 5, describing the custom-made design of a
phantom to accommodate the 2D monolithic array of silicon diodes named Octa. Both
the spine phantom and the Octa were designed at the Centre of the Medical Radiation
Physics. This chapter reports on the manufacturing of the phantom with the assistance of
computer-aided design (CAD) technology. The phantom was fabricated from polymethyl
methacrylate (PMMA).
Aim 4: Explore the Octa response as a function of the angle of incidence of radiation
beams, in a standard cylindrical geometry, with the array measuring in the coronal
plane (Figure 1).
Research question: is the Octa response angularly dependent, and if so, is it possible to
account for that dependence, regardless of radiation field size?
Based on the literature, it is expected that a planar monolithic array of silicon diodes such
as the Octa has a sensitivity to incident radiation that varies as a function of radiation
incident angle. Therefore, prior to using the Octa in the ‘spine phantom’ to measure dose,
the candidate needed to explore the angularly-dependent response of the array, and also
investigate if that varies as a function of radiation field size.
This research question is addressed in chapter 6. This study was performed considering
open fields of 10x10 cm2, 1x1 cm2 and 2x2 cm2 , all with 6 MV beams. Benchmarking
was done considering measurements with EBT3 films.
Aim 5: Explore the Octa response as a function of the angle of incidence of radiation
beams, in the custom-made phantom of Aim 3, with the array measuring in the
horizontal plane (Figure 1).
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Research question: is the Octa response angularly dependent, and if so, is it possible to
account for that dependence, regardless of radiation field size?
This research question is addressed in chapter 7. Similarly to the previous one, also this
study was performed considering open fields of 10x10 cm2, 1x1 cm2 and 2x2 cm2 .
Benchmarking was done considering measurements with a treatment planning system.
.
Conclusion: Finally, the last chapter, chapter 8, has final remarks and a summary of
contributions.
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Chapter 2-Literature review
2.1 Introduction
One of the requirements of the normal renewal process for tissues in the human body is
that existing stem cells reproduce themselves to maintain tissue size and function. The
unlimited proliferative capacity of these cells is the basis of the structure of the normal
epithelial and haemopoietic tissues of the body (Mayles et al., 2007). Cancer arises if
there is an uncontrolled manner in which neoplastic stem cells grow, spreading
cancerously to nearby tissues or to other parts of the body. The aim of cancer radiotherapy
treatment is to deliver a maximum dose to cancerous cells without affecting the healthy
tissue nearby. This can be achieved by giving careful attention to the dose distribution
together with the biological effects of the radiation. The biological effects depend on the
spatial and temporal distribution dose and on biological response processes. Two
biological response models, Tumor Control Probability (TCP) and Normal-Tissue
Complication Probability (NTCP), are used to establish accurate dose distributions.
Currently, a dose volume histogram is available as a dose shaping tool that can be used
to choose one of many alternative treatment radiation therapy plans.

2.2 External Beam Radiation Therapy Treatment (EBRT)
An X-ray linear accelerator (“linac”) is currently the most popular device to treat cancer
cells with high energy X-rays (Megavoltage range). Therefore, it is required to study the
penetrating characteristics of such radiation in the patient (Metcalfe et al., 2012). For
skin cancer, superficial X-rays (up to 150 kV energy) and orthogonal X-ray (up to 300kV)
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machines are used for treatment and palliation. These machines do not provide skin
sparing properties because they using low penetrating photons due to their low energy.
For more penetrating photons with higher energy, Cobalt-60 machines were introduced
which have two spectral peaks, 1.17 and 1.33 MeV, with mean energy 1.25 MeV. Photons
of such energy provide maximum dose at depth of about 0.5 cm in the human body and
provides skin-sparing. However, higher energy X-ray linacs are more appropriate for
radiotherapy applications rather than cobalt-60. X-ray linacs have many features such as
various electron and photon energies that allows the physician to choose the delivered
energy that is consistent with the requirements for the depth and width of the treatment
volume.
Figure 2 and Figure 3 illustrate a modern linac and its component, respectively. There are
many types of linac for clinical use. Modern linacs are currently available to provide
photon energies from 6MV to 18 MV and electron energies from 6 MeV to 22 MeV
(Podgorsak, 2005).

Figure 2. An example of a modern medical linear accelerator for radiation therapy (Metcalfe et
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al., 2012)

Figure 3. Schematics of the components of a modern linear accelerator for radiation therapy
(Metcalfe et al., 2012)

The main aim of radiation therapy treatment is to deliver a high dose to a volume of cancer
cells (target) while minimizing dose to the surrounding healthy tissue to protect the
critical structures or organs at risk (OAR). The International Commission on Radiology
Units and Measurements (ICRU) reports numbers 62 and 50 demonstrate the definition
of the target volume. The target volume is the anatomical volume irradiated by each
treatment; its margins minimized by delivering the correct dose. The main concepts
underlying any discussion of target volume are Gross Target Volume (GTV), Clinical
Target Volume (CTV) and Planning Target Volume (PTV) as illustrated in Figure 4.
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Figure 4. Schematics demonstrating key definitions in radiation treatment, in particular, the
gross target volume (GTV), clinical target volume (CTV) and planning target volume (PTV).
Adapted from ICRU report 50 (ICRU 1993).

These terms can be defined according to Shang et al. (Shang et al., 2015) as follows: the
GTV for the head and neck cancer (HNC) patients is “the gross extent of the primary
tumour and any cervical lymph nodes felt to be involved in imaging or physical
examination”. The clinical target volume is “the GTV plus a margin for potential
microscopic spread of disease as well as clinically negative but at risk regional lymph
nodes”. The planning target volume is “the CTV plus a margin, usually 3-5 mm,
depending on the image guidance techniques used and the frequency of image guidance
applied, to account for setup uncertainties”. In radiation oncology, head and neck cancer
(HNC) radiation therapy is one of the most technically challenging treatment because of
the number of tumours each with a different treatment dose, and the irregular surface of
this region. Intensity modulated radiation therapy (IMRT) and volumetric modulated arc
therapy (VMAT) are the most common techniques for HNC treatment (Shang et al.,
2015). In radiotherapy, image guidance usually accompanied by each radiation treatment
to achieve a high-quality result. Over time, image guidance has progressed from weekly
two-dimensional (2D) portal imaging to three-dimensional computerized tomography
(3D-CT) or cone-beam computerized tomography (CBCT).
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Three-dimension conformal radiotherapy (3D-CRT) was developed in 1980 to
eliminate the need for any additional surgical procedures and to improve dose
homogeneity in the target volume. This method needs a 3-D view of the target object and
it is composed of two opposed lateral (bilateral) fields and a third anterior field (Metcalfe
et al., 2012) (Figure 5). The two fields of 3D-CRT for HNC treatment are applied to
irradiate a primary tumour and cervical lymph nodes in the upper and lower neck. The
third field is applied to irradiate the supraclavicular lymph nodes. In order to avoid field
overlaps at the field junction line, all these fields are matched at the isocentre plane (Shang
et al. 2015).

Figure 5: 2D projection of unmodulated coplanar or non-coplanar beams for 3D-CRT.
(Metcalfe et al., 2012)

From 1990, Intensity modulated radiotherapy (IMRT) was used to reduce the intensity of
rays that are delivered to sensitive critical structures and to increase the received dose of
these rays in the target volume. Thereafter, the modulation of the intensity of radiation
beams could be used to produce a high conformity of the dose distribution with the target
volume (Bortfeld, 2006) as shown in Figure 6.
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Figure 6. Schematic illustration of the intensity modulate radiation therapy technique (Brahme,
1988).

There are two modes in IMRT. The first mode is the “dynamic” mode or “sliding
window” mode, where the beam is on and the mechanical parts are moved (Kijewski et
al., 1978). The second mode is the Step-and-Shoot mode, where the beam is off, and the
MLC moving. Palma et al. (Palma et al., 2010) observed a major difference between the
delivery time of the IMRT technique and the 3D-CRT, which could be in the range of 15
to 30 minutes for the IMRT whereas for the 3D-CRT delivery time could be just a few
minutes.

In 2007, volumetric modulated arc therapy (VMAT) was introduced where the gantry is
rotated around the patient while the beam is on. Three parameters can be changed during
VMAT: the beam shape, the rotation speed, and the dose rate. The main properties of
VMAT are that: (i) the radiation beam can be delivered by a conventional linear
accelerator (linac);(ii) a single rotation of VMAT can deliver the dose to the target and
the dose distribution can be improved by using another rotation (Palma et al. 2010). Thus
far, a number of studies (White et al., 2012, Verbakel et al., 2009, Tol et al., 2015) have
shown that the VMAT plan for HNC is composed of 2-3 full or partial arcs depending on
the target site (bilateral or unilateral). Gomez-Millan et al. (Gomez-Millan et al., 2015)
and Osborn (Osborn, 2017) demonstrated the benefit of VMAT for head and neck cancer
patients compared to IMRT. The VMAT technique introduced fewer monitor units, less
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delivery time and lower integrated dose to the body than the IMRT technique. Shang et
al. (Shang et al., 2015) reported that the VMAT technique is very suited to multileaf
collimators (MLCs) and gantry motion when the beam is on and can gain from
implementations capable of simultaneously modifying MLC speed, dose rate and gantry
speed.

Tomotherapy (i.e., slice therapy) is the rotation of a radiation source through 360° when
a patient’s body is moved through the radiation field. The radiation beam is delivered in
a fan-shape where the radiation beam is adjusted as the beam rotates (Figure 7). There are
two main techniques for tomotherapy: axial or serial tomotherapy and helical
tomotherapy. Axial tomotherapy is defined as the radiation beams being delivered slice
by slice, so the radiation beams treat a slice of the tumor before the patient’s body is
moved ready for the radiation beams to treat the next slice of tumor area. Helical
tomotherapy has the radiation beams being delivered in a continuous spiral and modulated
by a binary MLC with the patient’s body being moved continuously during the treatment
(Oliver et al. 2009).

Figure 7: Schematic of Tomotherapy (Yartsev et al., 2007)
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Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT) deliver a
high dose 8-24 Gy in a single fraction or 40-50 Gy in multiple fractions in a small field
to an inoperable tumour where surgery is not possible. In a study that investigated linacbased stereotactic radiotherapy techniques for treating pituitary adenoma and
craniopharyngioma, Varghese et al. (2018) reported that SRT techniques which include
static conformal fields (SCFs), static conformal arcs (SCAs) and dynamic conformal arcs
(DCAs) have delivered an accurate conformal and homogeneous dose to tumours with a
minimal delivered dose to healthy adjacent structures.

2.3 Quality assurance (QA) in radiotherapy
Quality assurance (QA) in radiotherapy involves all the procedures that are followed to
verify that the desired treatment has been administered, ensuring delivery of an accurate
high dose to the cancer and a minimal dose to the normal tissue. In order to measure or
predict the absorbed dose in tissue, there are two steps (Figure 8). The first step is
providing a suitable patient “phantom” to assess the deposited dose in human tissue. This
phantom should be radiologically similar to the human body and its density. There are
many types of phantom such as “slab” phantoms of layered solid water-equivalent
materials and “anthropomorphic” (human-shaped) heterogeneous phantoms. The second
step is to measure the deposited dose with a suitable dosimeter at a specific location in
the phantom. From the collected data, mathematical algorithms for the treatment planning
are created (Metcalfe et al., 2012).
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Figure 8: Setup for dosimetry of external radiation therapy (Metcalfe et al., 2012)

There are many types of dosimeters that are applied in radiation therapy such as
1-

Ionization chambers (parallel-plate, cylindrical ...etc.)

2-

Thermoluminescent dosimeters (chips, powder...etc.)

3-

Radiochromic films

4-

Silicon dosimeters

5-

Diamond dosimeters

6-

Fibre optics dosimeters

Ionization chambers are the most common dosimeters that are applied in radiotherapy and
are considered as a reference standard for other dosimeters such as MOSFETs. Therefore,
there are many QA reports published by various organizations and researchers outlining
procedures to be followed in radiotherapy treatment steps to ensure delivery a high dose
to the tumour and a minimal dose to the healthy tissue, such as the American Association
of Physicists and Medicine (AAPM TG-40) Report in 1994.

2.4 Dosimeters
The most common dosimeters used in radiotherapy are summarised in the following sub-sections:
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2.4.1 Ionization chambers
There are many types of ionization chambers depending on their geometry, materials, the
thicknesses of their walls, electrode materials and active interaction volumes (typically
air is used as a filling medium). Figure 9 illustrates the main components of parallel plate
ionization chambers where the filling medium is gaseous.

Figure 9: Illustration the components of the parallel-plate ionization chamber. 1-The polarizing
electrode, 2-the measuring electrode, 3-the guard ring, a- the height (electrode separation) of the
air cavity, d-the diameter of the polarizing electrode, m-the diameter of the collecting electrode,
g-the width of the guard ring. (Podgorsak 2005)

The main type of parallel plate ionization chamber is the Markus ionization chamber. It
consists of two plane walls, the first one acting as an entry window and polarizing
electrode and the second a collecting electrode, which also functions as a back wall. The
“guard ring” also an important part of an ionization chamber, since it provides a
homogeneous electric field between the two electrodes. The thickness of the guard ring
must be enough to prevent scattering of secondary electrons from walls. When the
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radiation beams are penetrating the dosimeter, the impact of radiation on the air cavity of
the chamber could be described as in Figure 10.

Figure 10: Chain of events after impact of an incident photon in the air cavity of an ionization
chamber(Metcalfe et al., 2012)

Kerma (kinetic energy released per unit mass) is proportional to the photon energy fluence
in any homogeneous material such as air. Secondary electrons are produced when primary
incident photons interact with the air, and a certain amount of energy is transferred during
Compton interactions. Collisional Kerma is related to kinetic energy of electrons
deposited to ionization in matter while part of kinetic energy of secondary electrons are
losing their energy through as bremsstrahlung (Radiative KERMA). The resulting ions
which are produced are collected in ionization chamber and measured by an electrometer.
Two types of Markus ionization chamber are now in frequent use: a classic Markus
chamber and an advanced Markus chamber. Table 1 describes briefly the geometric
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details of the classic Markus chamber and the advanced Markus chamber as illustrated in
Figure 11 (from Von Voigts-Rhetz et al., 2017).
Table 1: Geometric details of classic Markus and advanced Markus ionization chamber (Von
Voigts-Rhetz et al., 2017)
Chamber

v(cm3)

r(cm)

h(cm)

w(cm)

d(cm)

Classic Markus (PTW-23343)

0.055

0.265

0.2

0.035

0.13

Advanced Markus (PTW-34045)

0.020

0.25

0.1

0.2

0.13

Where:
1. v is the active chamber volume.
2. r is the radius of the active volume.
3. h is the height of active volume.
4. w is the width of the guard ring.
5. d is the thickness of the dose entrance window.

Figure 11: Illustration of the outer dimensions of an a) advanced Markus and b) classic Markus
ionization chamber. (von Voigts-Rhetz et al., 2017)

An advanced Markus parallel-plate ion chamber type 34045 (PTW, Freiburg, Germany)
was used for the surface dose and build-up region measurements described in this thesis.
The plate separation of the advanced Markus ion chamber is fixed at 1 mm and the
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diameter of the wall is 9 mm, whereby the scattered electrons are produced from the
sidewall and are measured in the active volume of the chamber.
In a comprehensive study of doses measured by ionization chambers, Velkley et al.,
(Velkley et al., 1975) introduced correction factors for electrons that are produced from
the sidewall of the chamber and cause perturbations in dose measurements. Gerbi and
Ghan (Gerbi and Ghan, 1990) reported that Velkley correction factors are valid for
chambers that have 5-11 mm distance between the collecting edge and the sidewall. In a
study conducted by Rawlinson et al. (Rawlinson et al., 1992), it was found that an overresponse in readings of plate parallel ionization chambers is dependent on the design
features of the chamber. The design of the advanced Markus chamber is different from
the original Markus chamber and has an overresponse correction factor of 3.3%, while
the overresponse correction for the original Markus is 10.1%.
Therefore, Rawlinson has modified the Velkley correction formula as follows:
P(d, E) = P’(d, E, G) – ξ (d, E, G)

(2.1)

ξ (d, E, G) = ξ (0, E, G) x e-4.0d/dmax

(2.2)

ξ (0, E, G) = c (E) x (s/w) x ρ0.8

(2.3)

Where:
1. P is the true PDD.
2. P’ is the measured PDD.
3. ξ

is an over-response correction factor.

4. E is the beam energy.
5. d is depth in the phantom.
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6. ρ is the mass density of the ionization chamber wall.
7. s/w is the ratio of electrode separation (s) to the inner diameter of the sidewall (w)
For E = 6 MV photon beam energy , dmax =15 mm and c (E) = 0.27 (Rawlinson et al.,
1992).
Another type of ionization chamber, the Octavius 1000SRS, is a 2D array of ionization
chambers consisting of 977 ICs (SVs) with 2.5 mm pitch in the 5 cm2 central area and 5
mm pitch outside this area. It was used for small field dosimetry and the main
characteristics include high accuracy and sensitivity (Loutfi-Krauss et al., 2017).
2.4.2 Radiochromic films
Radiochromic films perform two-dimensional (2D) dosimetry. They are used to measure
a dose range between 50Gy to 2500Gy in external radiotherapy (Devic et al.,2006).
Currently, Gafchromic brand EBT film is used in external radiotherapy. The main
characteristics of this film are it is independent of beam angle, dose rate and energy; it is
insensitive to visible light, it has high spatial resolution, and it does not need processing
because it is self-developing once exposed to radiation. Wen et al. (Wen et al., 2016)
provide a useful explanation of practical and efficient protocols for using Gafchromic
EBT3 film in SRS and SBRT to obtain absolute dose values. However, radiochromic
films require densitometry measurements and calibration of the densitometer to obtain
the relationship between the films’ measured optical density and the original delivered
dose.
2.4.3 Silicon dosimeters
Figure 12 illustrates the schematics of a MOSFET, a Silicon dosimeter that, at present, is
typically used in radiation therapy to measure the radiation dose on surface or in the buildup region. MOSFETs began to be applied for radiation dosimetry in 1980 and they have
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several valuable features. They provide an immediate readout, have a small size and a
good spatial resolution. The process of producing a signal occurs when the incident
radiation photon penetrates the oxide gate of the MOSFET which causes generation of
charges, which are trapped permanently at or near the SiO2/Si- substrate interface, causing
an alteration in the threshold voltage (Vth). Alteration of the Vth is proportional to the
absorbed dose. However, MOSFETs have a limited lifespan, specific to a given read-out
system.

Figure 12. Illustration of the components of a MOSFET (Metcalfe et al., 2012)

A new MOSFET dosimeter, the MOSkin, was designed by the University of Wollongong;
Centre for Medical Radiation Physics (CMRP). The MOSkin can provide a very accurate
measurements for skin dose because MOSkins can measure dose at a depth of 0.07mm,
in accordance with the International Commission on Radiological Protection (ICRP)
recommendation for radiosensitive basal layer measurements. Figure 13 illustrates the
difference in packaging design between MOSFETs and MOSkins (Safari et al., 2015).
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There are many other different silicon dosimeters used in radiation therapy dosimetry.
For instance, silicon diodes. Examples of that are the SFD diode (IBA Dosimetry,
Germany) and the Razor diode. They consist of a small sensitive volume of 0.6 mm
diameter. A common characteristic of all these devices is that they provide a simple,
convenient, linear conversion of dose to measured electrical charge, but they all have
varying degrees of (small) over-response when used in small field dosimetry (Garnier et
al., 2018; Tyler et al., 2013 & Liu et al., 2016).

Figure 13. MOSFET and MOSkinTM designs: a) MOSkin system b) Design of MOSFET with an
epoxy bubble encapsulation above the sensor c) MOSkin being operated in a “face –up”
orientation d) MOSkinTM being operated “face down”. (Safari et al., 2015).

There are now many types of the silicon dosimeters arrays available, but an important
issue with the dosimeter arrays is their angularly dependent response. The “dose
magnifying glass” (DMG) is a one-dimension array silicon dosimeter. It consists of 128
diodes with a 0.2 mm pitch and 0.375 mm p-type substrate thickness. It has been used for
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IMRT QA and SRS small field dosimetry. The angular dependent response of DMG on
PCB is 28% which is reduced to 12.8% when the DMG is mounted on a Kapton pigtail.
The MapCheck3 (Sun Nuclear Corporation, Melbourne, FL, USA) is a commonly used
two-dimensional array silicon dosimeter. This dosimeter is configured from 1527 n-type
diodes spread over an area of 0.64 mm2 with 7.07 mm spacing. This dosimeter is designed
for VMAT QA and it response exhibits a good match with TPS plans at different photon
energies 6, 8, 10 and 15 MV (Low et al., 2011). Another 2D dosimeter is the SRS Profiler
which has 125 diodes spread over four arrays (two orthogonal and two diagonals). The
CMRP has been developed several two-dimensional silicon array dosimeters including
the Magic Plate 512 (MP512), the DUO. The MP512 and Duo were the first generation
of monolithic silicon dosimeters arrays. The MP512 was designed with 2 mm pitch that
can exactly reproduce the penumbral region (Alrowaili et al., 2017). Its angular dependent
response could be corrected for use in small field dosimetry. The DUO dosimeter was
designed with two orthogonal arrays having 505 diodes in each array, spread over an area
of 52x52 mm2 with 0.2 mm pitch (AlShukaili et al., 2018).
The Delta4 (ScandiDos AB, Uppsala, Sweden) and the ArcCHECK (SunNuclear
Corporation, Melbourne, FL, USA) are three-dimension commercial dosimeters. The
Delta4 consists of 1069 cylindrical p-type diodes (each diode has a 0.05 mm thickness
and 1 mm diameter), arranged on orthogonal plane and embedded into a cylindrical
phantom. The ArcCHECK consists of 1386 n-type diodes with a 1 cm pitch on a HeliGrid
and the dimensions of each diode are 0.8 x0.8 x0.03 mm3 embedded within a cylindrical
phantom of PMMA with a central air cavity. Both the dosimeters have been used for small
field dosimetry.

2.5 Small fields dosimetry
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An ideal accurate dosimeter is one of the quality assurances tools for use with small field
beams. The main requirements for an ideal dosimeter are to be water equivalent, having
a small sensitive volume, be energy and dose-rate independent and allow a real-time
readout system. Accurate small field dosimetry can produce an accurate verification of
dose distribution predicted by TPS, and this leads to significant positive outcomes for
patients (Biasi, 2018). The ICRU (ICRU report 91, 2017) and the IAEA (IAEA-TRS483, 2017) have been demonstrated the challenges accompanying quality assurance in
small field dosimetry. These are challenges such as partial occlusion of the primary
source, loss of charge particle equilibrium (CPE) on the central axis and dosimeter
dimensions relative to the field beam dimensions which affects the particle spectra. The
effects lead to overlapping the penumbrae of the primary beams over the dosimeter
volume and produce inaccuracy in the dosimetry readings (Andreo, 2018).
The angular dependence of silicon arrays has been reported to be the main drawback of
silicon dosimeters because of the materials in the dosimeter sensitive volume and the
dosimeter assembly (Stansook et al., 2017). The secondary electron spectrum in a
sensitive volume depends on the angle of radiation beam which determined by it
packaging. This angular response of the dosimeter limits the accuracy in small field
dosimetry.

2.6 Skin dose and build-up region characteristics of X-ray
The absorbed dose in the skin region alters rapidly, and the alteration is dependent on the
photon beam energy, beam geometry, and electron contamination. The surface dose for
high-energy photons is lower than the maximum dose at depth (dmax), and that is known
as “skin sparing”. The International Commission on Radiation Units and Measurements
(ICRU) and the International Commission on Radiological Protection (ICRP) recommend
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that 0.07 mm is the depth of measurement for skin dosimetry where the basal layer is
located because it is considered to be one of the most radiation -sensitive layers.
X-ray photon beams include not just the primary photon that are produced from the linac
but also include electrons. When X-ray photon beams strike modifying devices such as
collimators, blocking trays and exit jaws, the generated electrons contaminate the column
of the air between the head of the linac and the patient. Therefore, the surface dose comes
from the primary photons, the electron contamination and the backscattered photon
interactions as shown in Figure 14 (Metcalfe et al., 2012).

Figure 14: Electron contamination of a primary X-ray beam (Metcalfe et al., 2012).

When the primary beam penetrates the patient to generate surface dose (Ds), high energy
x-rays and electrons interact with the patient (or phantom in a simulation) to produce the
“build-up region” (the region between 0 and dmax) and the dose in this region increases
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gradually until it reaches the maximum dose (Dmax) at a depth called dmax (Figure 15). The
dose after Dmax decreases exponentially until it reaches the exit dose (Dex) at the depth
(dex). The curve comprising the sum of all these processes is called the “percentage depth
dose” (PDD) curve, wherein all doses at different depths are normalized to Dmax and
multiplied by 100 (Podgorsak, 2005).

Figure 15: Percentage depth dose (PDD) (Podgorsak, 2005).

In Megavoltage X-ray beams, charged particles travel in the phantom or patient and
deposit amount of energy along their tracks; the absorption of this energy does not
necessarily occur at the same interaction site. Absorbed portion of energy is known as
“collision Kerma” in case of charge particle equilibrium (CPE).

Charged particle

equilibrium is attained when the energy transferred in and out of a certain volume by
charged particles is equal, so the condition of CPE does not exist at every depth under the
skin surface. The absorbed dose in the build-up region is smaller than collision Kerma.
At d=dmax the number of electrons reaches longitudinal equilibrium and CPE becomes
comparable with collision Kerma. Beyond dmax the curve falls off because of the loss of
28

photons by attenuation and scattering. The collision Kerma and the dose in this area
decrease, and this is called transient longitudinal equilibrium (Figure 16).

Figure 16: Illustration of the conditions related to CPE: a) CP disequilibrium b) Transient CPE
(Metcalfe et al., 2012).

By using beam modifying devices such as blocking trays and wedges with different beam
energies and field size, their effects on the percentage surface dose and build up region
was investigated by using different dosimeters (Kim et al.1998, Lamb and Blake 1998,
Butson et al. 1996, Kron et al. 1993 and Nilsson and Sorcini 1989).
Various phantoms and dosimeters have been used to evaluate the surface dose and buildup region and to assess the effect of altering beam parameters. Quach et al. (Quach et al.
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2000) investigated the surface dose at chest wall (breast) by using a hemicylindrical solid
water phantom with a 7.5 cm radius and three dosimeters: a GaF film (effective depth
0.17 mm), thin TLD (effective depth 0.14 mm) and a MOSFET device (effective depth
0.5 mm). The phantom irradiated with 6MV X-ray, at 100 cm source surface distance
(SSD), with field sizes of 20 x 20 and 10 x 20 cm2. Various beam incidence angles were
used from 0 to 180º to obtain a surface dose profile with 10º increments around the
circumference of the phantom. The surface dose at 0º and 90º was found to be,
respectively 28 % and 58 % of dmax by using GaF film, 30 % and 57 % by using TLD and
43 % and 62 % by using MOSFET. The differences in results were attributed to the
effective depth of measurement for each dosimeter.
An optically stimulated luminescence dosimeter (OSLD) ( Yusof et al.2015) was used to
measure surface dose in a slab phantom and in a breast phantom in comparison with in
the clinical measurement of 10 patients during tangential breast treatment. The surface
dose of the treated breast or chest wall and on the contralateral breast during tangential
breast radiotherapy was evaluated. It was demonstrated that the water equivalent depth
(WED) of the OSLD is 0.4 mm. The study used the OSLD, a Markus ionization chamber
and Gafchromic EBT3 film to measure surface dose on a solid water slab phantom. The
measured surface dose normalised to dmax, was 15.95 %, 12.64 % by the Markus ionizing
chamber, 23.79 %, 17.14 % by the EBT3 film and 37.77 %, 25.38 % by OSLD for 6 and
10 MV, respectively. For the surface incident beam, the surface dose increases when the
incident beam angle increases as expected. For all measurements on the breast phantom
and on a patient OSLD measured always higher dose than by EBT3 film. Another study
evaluated the surface and build-up region doses (Akbas et al. 2016) for 6 MV and 15 MV
photon beams by using three dosimeters; a Markus ionization chamber, EBT3 film and a
MOSFET dosimeter. The dosimeters were irradiated with a beam incident under different
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angles 0°, 30°, 60° and 80° and different field sizes 5 x 5, 10 x 10 and 20 x 20 cm2. The
surface dose measured for 6 MV photon beam and field size 10 x 10 cm2 by the Markus
chamber was 20.3 %, 18.8 % by the EBT3 film and 25.5 % by the MOSFET dosimeter.
For 15 MV photon beam and 10 x 10 cm2 field size, the surface dose was 14.9 % as
reported by the Markus chamber, 13.4 % by the EBT3 film and 16.4 % by the MOSFET
dosimeter. The surface dose encountered at different incidence angles were investigated.
It was demonstrated that surface dose is increasing when the field size and/or the
incidence angle of the radiation beam was increased.
Numerous studies were carried out to derive correction for measured skin dose assuming
reference depth is 0.07 mm. Devic et al (Devic et al., 2006) determined skin dose by
using radiochromic film for 6 MV x-ray beams. The study included using three types of
GAFCHROMIC dosimetry film, HS, EBT, and XR-T. These dosimeters measured the
dose at WED larger than 0.07 mm, and required 15-16 % correction to adjust readings to
the dose at 0.07 mm. Furthermore, the study used an Attix parallel –plate chamber and a
home-built extrapolation chamber to measure the dose in the depth range of 4 µm to 1
mm. The results showed the PDD increased from 14 % to 43 % by using 6 MV photon
beam with a field size of 10 x 10 cm2 in the first millimetres of the skin region confirming
that thickness of the sensitive volume of the dosimeter and its packaging are critical for
accurate skin dosimetry at depth 0.07 mm. The study demonstrated an effective procedure
that used GAFCHROMIC EBT to get an accurate measurement of the skin dose in a
parallel-opposed pair 6 MV beam arrangement. The surface dose for IMRT fields has
been evaluated by using an advanced Markus ionization chamber (Chen et al. 2010). To
measure the surface dose at depth 0.07 mm accurately by using an advanced Markus
chamber, an extrapolation method was used by adding a single layer polymer protector
sheet on the top of the chamber. Therefore, the PDD dose at 0.07 mm of a 12 x 12 cm2
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field size was found to be 19.8% for the open field and 19.2 % for the unmodulated step
and shoot (SS-IMRT) field.
Kwan et al. (Kwan et al. 2008 & Jong et al. 2014) reported that a new MOSFET based
dosimeter, the MOSkin, could provide accurate measurements of the skin dose in
radiotherapy. The MOSkin is used to measure the skin dose at an equivalent depth of 0.07
mm and the MOSkin measurements revealed an excellent agreement with the Attix
chamber in a 6 MV photon beam of various field sizes. The main advantages of this
dosimeter are that it can measure dose at 0.07 mm, its small size, and its real-time readout.
The characteristics of MOSkin dosimeter have been extensively evaluated, including
reproducibility, linearity, and the response for different dose rates at different gate bias.
A Markus ionization chamber and EBT3 film was also used to measure the surface dose
and then to compare their results with the MOSkin results (Jong et al. 2014).
A MOSkin dosimeter was used to evaluate the increase of skin dose during megavoltage
X-ray beam irradiation (Alnawaf et al. 2012). The outcomes revealed the MOSkin has a
minimal effect on increasing the measured skin dose under the detector (the device has
0.25 mm total thickness) in comparison with TLD. The maximum percentage skin dose
measured with the MOSkin was 15 % and 10 % with field size 10 x 10 cm2 for 6 and 10
MV photon beam, respectively. Furthermore, the skin dose measured by the LiF TLD
technique (1mm thickness) was measured to be 32 % and 26 % for 6 and 10 MV,
respectively.
The skin toxicity was observed for head and neck patients treated with IMRT, Lee et al.
(Lee et al., 2002) suggested that the reasons for skin toxicity for head and neck patients
who were treated with IMRT might be; the bolus effect of the masks commonly used, the
use of multiple oblique incident beams and the skin being considered as part of the target
volume. Another study by Higgins et al (Higgins et al 2007) assessed the surface dose for
32

three delivery techniques for head and neck treatment with: bilateral field, IMRT, and
tomotherapy as a percentage of the dose in a target. The results revealed that surface dose
for IMRT was the highest at 82% then tomotherapy at 71 % and finally bilateral fields at
69%.
Conversely, Dogan and Glasgow (Dogan and Glasgow, 2003) attributed the increase in
the skin dose for IMRT not to the IMRT technique itself, but instead found that the surface
dose for 6 MV IMRT at 0º and 75º incidence angles were lower for (1.6-8.8) % than the
measurement under the open field depends on a field size. In both cases dose
measurements were done at depths 2 and 5 mm by using the parallel-plate ionization
chamber at the same angles of the beam incidence. However, Yokohama et al.
(Yokohama et al. 2004) found that at 2 mm depth, the skin dose in the IMRT field was
lower than of the open field by 10 %.
2.5.1 The effect of immobilization devices and bolus materials on skin dose
In head or neck radiotherapy, the head immobilization devices (head mask) and bolus
materials significantly enhance the skin dose. A bolus could be considered as a build-up
material when the clinician is concerned about a near- surface recurrence. Mutic and Low
(Mutic and Low,2000) and Hsu et al., (Hsu et al.,2008) evaluated the superficial depth
dose distribution from serial tomotherapy treatments of geometric target volumes. In the
Mutic and Low study (Mutic and Low, 2000); the differences between the calculated and
the measured dose were determined and provided insight into the need for bolus on
superficial target volumes by using a commercial computer-controlled treatment planning
and delivery system. A cylindrical target volume with 5 cm diameter and 5 cm long was
embedded in a water-equivalent cylindrical phantom with dimensions of 16 cm diameter
and 12 cm long. TLD chips with dimensions 3 x 3 x 1 mm2 were used to measure doses
at centrally located, off-centred and superficial target volumes. The results indicated that
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calculated doses were slightly lower than the measured doses where the measured dose
in the build-up region required the use of a bolus to deliver the prescribed dose to the
phantom surface. Thermoplastic masks with 0.25 cm and 0.4 cm diameters of holes were
used to assess their impact on the build-up region for 6MV and 15 MV (Póltorak et
al.,2016). The surface dose for 6 MV was increased from 10 % to 42 % and for 15 MV
was increased from 5 % to 28 % when using a mask.
Also, the effect on the skin dose and build-up region of immobilization devices and beam
modifier has been investigated (plaster and thermoplastic casting materials) , for example,
the study by Fiorino et al. (Fiorino et al., 1992) used immobilization plastic masks for
head and neck radiotherapy with megavoltage photon beams radiation. In their study, the
effect of filters, wedges, and blocks between the patient and the accelerator on the skin
dose was evaluated. Moreover, the effect of using 2 and 3.2 mm of plastic material on the
skin dose for head and neck irradiation patients with 6 MeV X-rays was measured by a
NE2534 chamber (Markus type) on a polymethylmethacrylate (“PerspexTM”) phantom.
Fontenla et al.( Fontenla et al., 1994) used a polystyrene phantom irradiated with 6 and
15 MV photon beams at two different source-to-phantom distances and various field sizes
. They found that 79 % of the maximum dose was delivered when 3 mm solid
thermoplastic casting material was used with 6 MV and 12 x 12 cm field size, while only
22% of the maximum dose was encountered when no beam modifiers or immobilization
devices were used.
Many studies have investigated the effect of techniques used to deliver doses to tumours
with a build-up bolus interposed. The reasons for severe skin reactions for head and neck
patients who received IMRT have been investigated (Lee et al., 2002). The skin dose
increases by 18 % with a mask for opposed lateral and Extended Field- IMRT (EF-IMRT)
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when the skin is considered as part of the target volume and multiple oblique incident
beams are applied.
Another study measured the skin dose in a phantom in the presence of patient
immobilization devices by applying EBT film during 6 MV conventional and 6 MV, 15
MV

IMRT

treatments

(Chiu-Tsao

and

Chan,

2010).

Several

different

immobilization/support devices were applied, namely: an OrfitTM carbon fibre base plate,
a carbon fibre grid with a MylarTM sheet, Styrofoam, Alpha –CradleTM and perforated
AquaPlastTM sheet, were used. In this study, the 2D skin dose distribution, isodose curves,
and cross-sectional profiles at the surface with or without the immobilization/support
device were determined. Significantly, the 2D bolus effect on skin dose with EBT film
was evaluated in the presence of immobilization/support devices in vivo. Lee et al.,( Lee
et al. 2002) investigated the effect of a technique used for head and neck cancer patients
who were treated with multiple tangential extended-field intensity modulated
radiotherapy (EF-IMRT) through a thermoplastic mask. An anthropomorphic RandoTM
phantom and six TLDs were used to measure the skin doses with and without a mask. The
dose volume histogram (DVH) of multiple tangential EF-IMRT was compared with the
DVH of conventional opposed-lateral fields and four alternative IMRT plans were
produced. IMRT plans that contoured neck nodes up to and containing skin surface were
compared with plans that contoured neck nodes 5 mm away from skin dose. Similarly,
IMRT plans that defined the skin as a sensitive structure and the plans that did not define
the skin as a sensitive structure were also compared. The results showed that the skin dose
with the mask was higher than without a mask in all four plans. Multiple tangential EFIMRT plans exhibited an increasing skin dose of 27 % with the mask and 19 % without a
mask. The optimization plans programmed to regard the skin as a sensitive structure
reduced 20 % of the skin dose.
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A number of effects that accompany surface doses when using different bolus materials
for conventional and the intensity modulated radiation therapy (IMRT) tangential fields
have also been explored (Hsu et al., 2008). In this study, three different types of bolus
material were used namely: 2mm solid, 3.2 mm large mesh and 2mm fine mesh
AquaplastTM. They compared these with SuperflabTM. An Attix chamber in a flat solid
water-equivalent phantom was used to measure the surface dose at 0º, 45º and 70º
incidence angles. Therefore, for those specific angles, over-response correction factors
could be calculated and applied to the Attix parallel plate chamber results.

An

anthropomorphic phantom and a TLD extrapolation method were used to measure
surface dose. The differences in the surface doses were found to be insignificant between
conventional and IMRT tangential fields, while the bolus effect for 2mm fine mesh
Aquaplast was large, up to an 82 % increase for chest wall tangential radiotherapy.
In another study for Aquaplast thermoplastic was used as a bolus during treatment of
superficial lesions on an irregular surface (Huang et al., 2006). Aquaplast RTTM
thermoplastic is a type of equivalent tissue bolus that can be moulded and located on
irregular surface. The authors concluded that Aquaplast RTTM thermoplastic bolus is
helpful in delivering a sufficient dose to skin cancer. The effect on surface dose of using
various bolus materials by using a 10 mm thick Vaseline bolus, a 3mm Superflab bolus
and a brass mesh bolus for 6 and 15 MV photon radiotherapy has been explored by
Ordonez-Sanz et al. (2014). Solid water-equivalent and anthropomorphic phantoms with
an ionization chamber and TLD dosimeters were used to study this effect. The results
showed that the brass mesh bolus increased surface dose with only a slight effect on the
depth dose curve (DDC) (Al-Rahbi et al 2018).
2.5.2 Treatment planning system and skin dose
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Radiotherapy treatment planning (RTP) or a treatment planning system (TPS) is the
process of setting a program of treatment instructions aimed at delivering a pre-defined
dose distribution in the patient as determined by an algorithm. Inaccuracies in the TPS
when calculating surface dose during radiotherapy have been studied and attributed that
to the lack of a build-up region near surface (Jong et al., 2016, Fraass et al., 1998, Court
et al., 2008, Panettieri et al., 2009, Chakarova et al., 2012, Akino et al., 2013). Several
studies compared doses calculated by treatment planning systems for various techniques
with doses measured by dosimeters to verify the skin dose.
The MOSkin was designed for accurate measurements in skin dosimetry. The in vivo
skin dose measurements for this new dosimeter were verified by comparison with planeparallel ionization chambers and radiochromic films (Qi et al., 2009). The accuracy of
the treatment planning system (TPS) for skin dose was evaluated by the IMRT of
nasopharyngeal carcinoma. The surface and build-up region dose measurements using the
new dosimeter agreed with an Attix ionization chamber and radiochromic film
measurements, even for oblique incident beams while the difference from TPS
calculations were within measurement uncertainty.
Another study compared between different TPSs. Pinnacle TPS and Eclipse TPS for the
breast with a bolus layer were compared (Masunum et.al. 2016). The bolus thicknesses
tested were 5 mm and 10mm with 200 cGy total doses to the breast. The two algorithms
provided two plans using a tangential field technique with a 6 MV photon beam. TLD
was used and calibrated with a Co-60 source. The results showed agreement in the buildup region for both algorithms. However, for lungs, there was an overestimation by the
Eclipse TPS with differences of 13.78 % and 6.06 % for both bolus thicknesses
respectively when controlled by the Pinnacle TPS, while TLD results showed a slight
underestimation in the build-up region for the breast.
37

Chung et al. (Chung et al.,2005) conducted experiments to determine the dosimetric
discrepancies in the surface and build-up region between the TPS prediction and the
experimental measurement by using radiochromic film on a head and neck compression
phantom. Two commercial TPSs were generated (PINNACLE and CORVUS) for two
cases, shallow and deep targets (0.5 cm and 6 cm depth) with 54 Gy prescribed dose. For
each case, two pieces of radiochromic film were used, one on the surface and the other
inserted into the phantom. The results showed that there was a good agreement for both
TPSs with the measured doses but there were significant discrepancies from the surface
to about 0.2 cm in depth for both cases.
The skin dose for head and neck patients who were treated with tomotherapy monitored
by using MOSFET and TLDs has also been evaluated (Kinhikar et al., 2009). The skin
dose in the tomotherapy treatment planning system was found to be overestimated by
about 10-20 % when compared with MOSFET and TLD readings.

2.7 Verification of dose with Monte Carlo simulation
Modern particle physics Monte Carlo (MC) methods are deemed an acurate tool for dose
estimation in radiotherapy. The MC method can be used to characterize the particle
movements transport inside a material and explore different physical effects such as
interaction and number and types of secondary particles. The GEANT4 (GEmetry ANd
Tracking 4) software package is a Monte Carlo simulation Toolkit that can be use it for
modeling the interactions and transport of particles within matter (Guatelli et al., 2011).
GEANT4 is used a collection of C++ classes in the GEANT4 collaboration. In
radiotherapy applications, it is employed to verify dose in TPSs and to improve various
dosimeters characteristics when used in experimental measurements (Scott et al., 2008;
Sheikh‐Bagheri et al.,2000 & Andreo, 2018).
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Part 1- The MOSkin dosimeter
The MOSkin dosimeter is a MOSFET-based dosimeter and packaging designed at Centre
for Medical Radiation Physics to measure skin dose. The MOSkin packaging design is,
according to Kwan (2009): “The MOSFET sensor is dropped into a thin layer of Kapton
and hermetically sealed with a water-equivalent flexible polyimide film of highly
reproducible thickness”. The film functions are to protect the electronics from the damage
caused by moisture, avoid direct contact with patient’s body, connect the MOSFET sensor
by thin aluminum contact and provide 0.07 mm build-up layer of water equivalent depth.
The dimensions of the MOSkin sensor are 0.8 x 0.6 x 0.35 mm3 with 0.55 µm thickness
of gate oxide to provide a high spatial resolution of measurements (Kwan 2009). The
MOSkin packaging dimensions are 10 x 1.8 x 0.45 mm3 (Figure 17). MOSkins provide
real time measurements with a negligible perturbation of the radiation field; it is possible
to optimize its sensitivity and reproducibility by varying the silicon oxide thickness and
varying the bias external voltage applied on the gate electrode (Jong et al., 2014).
The MOSkin dosimeter system consists of MOSkin reader, MOSkin dosimeter and
connected wires (Figure 18). The read-out process is achieved by measuring the voltage
across the oxide gate, called the threshold voltage (Vth) and increment of the Vth is
proportional to the absorbed dose.
Many studies have reported the suitability and reliability of using the MOSkin dosimeter
for real time in vivo skin dosimetry in different radiation therapy applications (Kwan et
al. 2008; Jong et al. 2014; Al-Rahbi et al., 2018; Jamalludain et al., 2019; Qi et al.,2009; Kelly
et al., 2011; Quach et al., 2000; Hardcastle et al., 2008; Hardcastle et al., 2010& Qi et al., 2011).
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Figure 17. Schematics of a MOSkin dosimeter (a) MOSkin side view (b) MOSkin top
view (Kwan 2009).

Figure 18. MOSkin dosimeter system consists of MOSkin reader, MOSkin dosimeter and
connected wires (Al-Rahbi 2018)
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Chapter 3- Investigation into the MOSkin design, to improve
its sensitivity and lifespan.
This chapter presents a material published in Biasi et al., (2020) On the Combined Effect
of Silicon Oxide Thickness and Boron Implantation Under the Gate in MOSFET
Dosimeters. IEEE Transactions on Nuclear Science, 67(3), pp.534-540. The candidate
has actively participated at all steps of the research and coordinated measurements and
data analysis.

3.1 Introduction
In image guided radiation therapy, cone beam computed tomography (CBCT) uses either
6 MV or kilovoltage photon beams. Historically, imaging dose has been ignored despite
additional dose being delivered to organs (Alaei and Spezi, 2015). Recently, the MOSkin
was used for dose monitoring in CBCT (Quinn et al., 2011) and in CT (Pereira et al.,
2019). Quinn et al. and Pereira et al. reported that the minimum detectable dose for the
MOSkin was 0.401 cGy and 0.149 cGy in megavoltage photon beams and in x-ray tube
operating at 150 kVp, respectively.
This chapter describes investigations performed to study the related effects of SiO2
thickness and boron implantation under the gate on the sensitivity and lifespan of a
MOSFET device. The boron (B) implantation under the gate oxide was performed before
growing the SiO2 layer. The basic MOSFET device was as described in the literature
review (Chapter 2). The MOSFET has source, drain, gate (SiO2, the radiation sensitive
volume) and n-type substrate and there are p+ regions which are forming the source and
the drain.
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During exposure to radiation, when an external positive bias applied to the gate of the
MOSkin, its response (as in equation 3.1) is linear with absorbed dose (D) and the
sensitivity (S) to ionization radiation.
S=

𝛥𝑉𝑡ℎ
𝐷

2
≈ 𝑘1 𝑡0𝑥
𝑓𝐸

…… ( 3.1 )

Where the constant k1 is
k1 = 39 (

𝑚𝑉

𝑐𝐺𝑦 𝑢𝑚2

)………..

(3.2)

Equation (3.1) shows that MOSkin sensitivity can be modified either by making a SiO2
of various thickness (tox) or changing the external bias applied during irradiation to act on
the fractional yield (fE).

3.2 Methodology
In this study, various MOSkins were considered, with a different thickness of the SiO2
and a different amount of boron implantation under the gate. The thickness of SiO2 was
either 0.68 µm or 1.0 µm and the amount of boron implantation under the gate was either
0.0 (non-implanted), 0.2 or 0.6 µC/cm2. The MOSkin was primarily established for skin
dosimetry in radiation therapy (Kwan et al., 2008). The MOSkin packaging was as
described above and show in Figure 17 to be suitable for skin dosimetry.
The MOSkin threshold voltage reader was correct to within ±1 mV; its voltage cut-off
was 26 V; drain-source current was ~100 μA. The current was set at the thermostable
point to reduce dependence on temperature (Buehler et al.1993)
The linearity of the response as a function of absorbed dose was evaluated by irradiating
the MOSkin in 6 MV photon beams delivered with a linac. MOSkins were positioned on
top of 10 cm of solid water-equivalent slabs as a backscatter, at 1.5 cm maximum depth,
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at 100 cm a source-to-surface distance (SSD) and their top surface were aligned
perpendicular to the central axis of the beam. In active mode, the external positive bias
supplied was 15 V on the gate during irradiation and in biased mode, source, substrate
and drain terminals were all grounded. To evaluate the MOSkin sensitivity in MV photon
beams, the same experimental conditions were used as a function of absorbed dose. The
limits of the voltages on a gate used were 15 and 150 V to evaluate the MOSkin sensitivity
as a function of the external positive bias used on the gate during irradiation.
Furthermore, X-ray tube voltages of 50, 75, 100 and 150 kVp were used to irradiate
MOSkins in the photon beam. MOSkins were positioned on top of 30 cm of solid waterequivalent slabs, at 30 cm SSD and they were aligned with the central beam axis. The
sensitivity was evaluated as a function of X-ray tube voltage when the external MOSkin
bias was 15 V on the gate during irradiation; further, the device sensitivity was evaluated
as a function of the bias on the gate for tube voltages of 50 kVp and 125 kVp. The means
were reported as outcomes and the uncertainty were reported as two standard deviations.
Each irradiation was repeated at least twice, and all values of absorbed dose are reported
as dose to water.

3.3 Results and discussion
3.3.1 Decrease of the initial threshold voltage
The initial threshold voltage for the MOSkins (Vth) is shown in Table 2. When other
factors are kept equal and the thickness of the SiO2 layer(tox) is increased, the initial
threshold voltage climbs higher. Back in 2014, Alshaikh et al. (Alshaikh et al., 2014)
reported that the initial threshold voltage of a virgin MOSkin (SiO2 of 0.55 μm, nonimplanted) was about 7.0 V; the recent MOSkins used in this study, had Vth =12.36±0.17
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V for a non-implanted MOSkinTM with a 0.68 μm thickness of SiO2 and used readout
current.
Table 2: MOSkin explored; each initial threshold voltage refers to the average calculated
over three MOSkins with the same construction ± 2 standard deviations.

MOSkin

tox

B-Implantation

[#]
3
6
7
11
14

[µm]
0.68
0.68
0.68
1
1

[µc/cm ]
0
0.2
0.6
0.2
0.6

2

Initial Vth
[V]
12.362±0.166
11.543±0.242
10.116±0.180
16.273±0.455
14.924±0.399

In the study of Haran et al. (2005), increasing levels of B implantation was decreased the
initial threshold voltage. In our study this outcome was confirmed. When the thickness of
SiO2 was of 0.68 μm, the initial threshold voltage decreased by about 0.819 V between
non-implanted MOSkins and those implanted with 0.2 μC/cm2 of B. The Vth then
decreased by about 1.427 V between implanted levels of 0.2 μC/cm2 and those implanted
with 0.6 μC/cm2. Also, when the thickness of SiO2 was increased to 1.00 μm, the initial
threshold voltage decreased by about 1.349 V between MOSkins implanted with 0.2
μC/cm2 B and those implanted with 0.6 μC/cm2.
Whatever the thickness of the SiO2, in our study there was a decreased of the initial
threshold voltage of about 4.1 V for each 1 μC/cm2 of B implantation in the limit from
0.0 and 0.2 μC/cm2. Next, the decrease was of about 3.5 V for each 1 μC/cm2 of
implantation when changing the B concentration from 0.2 to 0.6 μC/cm2.
3.3.2 Response linearity as a function of absorbed dose
The relationship between MOSkins response and the absorbed dose was linear (Figure
19).
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Figure 19: MOSkins response linearity as a function of absorbed dose; external bias during
irradiation was 15 V. (3,6,7,11 and 14 refers to MOSkins as in Table 2)

The response was linear in the range from 0 to 4400 cGy and from 0 to 1500 cGy for nonimplanted MOSkins with a SiO2 thickness of 0.68 μm or 1.00 μm, respectively. That
range was from 0 to 5000 cGy and from 0 to 1700 cGy for implanted MOSkins with a
SiO2 of 0.68 μm and of 1.00 μm, respectively. The MOSkins with the 1.00 μm thickness
of SiO2 had a shorter range because of their higher sensitivity (the linear dynamic range
was limited by the reader voltage cut-off of 26 V was reached at a smaller absorbed dose
level).

3.3.3 Sensitivity as a function of photon energy
Jong et al. (2017) used 6 MV photon beams (effective photon energy of about 1 MeV)
and reported that the sensitivity of a MOSkin with 0.55 μm thickness of SiO2 (no boron
implanted) and a bias of 15 V during irradiation, was about 2.49±0.06 mV/cGy.
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In this study, when the SiO2 thickness was increased, sensitivity increased (Figure 20,
Table 3).
Table 3: Initial sensitivity (S) of virgin MOSkins in Megavoltage photon beams. Similarly,
sensitivity averaged (Ŝ) over the whole range of linearity; its spread/error is measured as 2
standard deviations.

tox

B-Implantation

[µm]
0.68
0.68
0.68
1
1

[µC/cm ]
0
0.2
0.6
0.2
0.6

2

S

Ŝ

[mV/cGy]
3.443±0.031
3.483±0.042
3.383±0.042
7.073±0.101
6.930±0.060

[mV/cGy]
3.266±0.236
3.352±0.030
3.130±0.463
7.008±0.143
6.818±0.177

By using equation (3.1), measured sensitivities can be compared to calculated sensitivities
for 0.55 μm thickness of SiO2 and, as a first estimate, using the values of the constant k1
and of fractional yield (fE), as approximately independent of the thickness of the SiO2.
The calculated sensitivity for 0.68 μm thickness of SiO2 was 3.807 mV/cGy (vs. a
measured value in the limit from 3.130 to 3.352 mV/cGy, Table 3); that for SiO2 of 1.00
μm thickness was 8.233 mV/cGy (vs. a measured value in the limit from 6.818 to 7.008
mV/cGy, Table 3).
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Figure 20: MOSkin Sensitivity as a function of absorbed dose in megavoltage photon beams:
external bias during irradiation was a constant 15 V (3, 6, 7, 11, 14 refer to MOSkins in table 2).

Changes between calculated and measured values are clarified by the dependence of the
constant k1, and of the fractional yield, on the thickness of the SiO2; in thicker SiO2 there
is a smaller electric field (in units V/μm), the recombination process is more effective,
and the fractional yield is smaller (Schwank et al., 2008 and Shaneyfelt et al., 1991).
MOSkins in high-energy photon beams were only irradiated by energies up to 6 MV
because in the megavoltage photon limit (up to ̴ 25 MV), MOSkin sensitivity is constant
(Ramani et al. 1997; Ramaseshan et al. 2004 & Halvorsen 2005).
When exposed to low-energy X-ray photons (“soft x-rays”) from 10 keV to 200 keV,
MOSkins are supposed to have reach a sensitivity limit which ( normalized to its
sensitivity in high-energy photons of a few MeV) is bigger by a factor of 3 to 4. At photon
energies around 50 keV, Sensitivity of the MOSkin is maximum (Edwards et al., 1997 &
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Kron et al., 1998) that determined photo effect cross section energy dependence and
MOSFET packaging.
Pereira et al. (2019) reported that the sensitivity of a MOSkin when photon beams were
produced with x-ray tubes running at 100 kVp, 120 kVp and 150 kVp was 9.21 mV/cGy,
7.69 mV/cGy and 6.72 mV/cGy, respectively for the gate bias 15 V. Sensitivity reduced
as a function of x-ray tube voltage, in addition, sensitivity at 100 kVp was about 3.7 times
that in 6 MV photon beams under the same gate bias 15 V during irradiation.
In our study, we confirmed those trends in MOSkin sensitivities (Figure 21, Table 4);
specifically, sensitivity at 100 kVp was about 5 times that in 6 MV photon beams, when
comparing devices with the same thickness of SiO2 and level of B implantation.
Table 4: Initial sensitivity (S) of virgin MOSFETs in 50 kVp and in 100 kVp photon beams

tox

B-Implantation

[µm]
0.68
0.68
0.68
1
1

[µC/cm ]
0
0.2
0.6
0.2
0.6

2

S, 50 kVp

S, 100 kVp

[mV/cGy]
22.100±1.131
21.567±0.808
20.433±1.007
38.067±0.945
37.300±1.744

[mV/cGy]
18.200±0.346
19.100±1.311
18.100±1.400
38.033±2.579
33.033±2.996
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Figure 21: MOSkin sensitivity as a function of orthovoltage x-ray tube running voltage. External
bias during irradiation was kept constant at 15 V throughout (3, 6, 7, 11 and 14 refers to MOSkins
in table 2).

In Haran et al. study (Haran et al., 2005), boron implanted MOSkins had a higher
sensitivity than non-implanted ones. That outcome was clarified in terms of further
defects being generated in the SiO2 because of boron being implanted during the SiO2
formation through the gate oxide. In this study, implantation was achieved before
increasing the SiO2 thickness to nominal value. That sensitivity did not alter as a function
of boron implantation concentration; instead, sensitivity was determined by the thickness
of the gate oxide and by the properties of the SiO2.
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3.3.4 Sensitivity as a function of external bias
Figure 22 and Figure 23 display the relationship between sensitivity and external bias
used on the gate during irradiation (Vg). In both megavoltage and kilovoltage photon
beams, when positive external bias was increased, MOSkin sensitivity also increased.
In megavoltage beams, the highest bias needed for operation was about 90 V for MOSkins
with a 0.68 μm thickness of SiO2 . The corresponding value was about 120 V for MOSkins
with a SiO2 thickness of 1.00 μm where the saturation produces a full charge collection.
In kilovoltage beams, the highest bias used (90 V) did not produce a full charge collection
in any of the MOSkins. Those outcomes are clarified by taking into consideration the
fractional yield as a function of the electric field in the SiO2. When the photon irradiation
beam energy is kept equal, the thicker the SiO2 , the greater the positive external bias
needed to create the same electric field and, in consequence, to saturate the fractional
yield. Alternatively, when thickness of the SiO2 layer is kept equal, a denser electron-hole
pair plasma is created by low-energy photons. To saturate the fractional yield a stronger
electrical field is needed (Schwank et al. 2008 & Shaneyfelt et al. 1991).

50

Figure 22: MOSkin sensitivity as a function of positive external bias used on the gate during
irradiation in megavoltage photon beams (3, 6, 7, 11 and 14 refers to MOSkins in table 2).
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Figure 23: MOSkin sensitivity as a function of positive external bias used on the gate during
irradiation. Irradiation was in beams formed with orthovoltage x-ray tubes operating at voltages
of (a, b) 50 kVp and (c, d) 125 kVp (3, 6, 7, 11 and 14 refers to MOSkins in table 2).

3.3.5 Instability of the threshold voltage
In a prior study from Haran et al. (Haran et al., 2005), B implantation reduced the
instability of the threshold voltage each time the MOSFETs were used with an external
bias. Similarly, MOSFETs with a 1.00 μm thickness of SiO2 yielded measurements with
less variability than MOSFETs with a 0.40 μm thickness of SiO2 . This was, probably, a
consequence of the poorer reproducibility of the thicker SiO2 gate oxide.
In this study, B implantation had no influence on the instability of the threshold voltage
in MOSkins used under external bias. Instead, the instability of the threshold voltage was
determined by the thickness of the SiO2 and the power of the external bias (Figure 22 and
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Figure 23). MOSkins with a 0.68 μm thickness of SiO2 yielded measurements which had,
on average, a reproducibility 1% better than those with a 1.00 μm thickness of SiO2,
whatever the B implantation; reproducibility worsened when the external bias was
increased above 80 V.

3.4 Conclusion
This study explored the related effect of the thickness of the SiO2 layer and the level of
boron implantation in MOSkinTM dosimeters. The thicknesses of SiO2 that were used in
this study were either 0.68 μm or 1.0 μm while boron implantation level was either 0.0
(non-implantation), 0.2 or 0.6 μC/cm2.
The main outcomes of this study are that MOSkins with a thicker SiO2 had an improved
sensitivity under the same gate bias during irradiation. However, increasing of initial
threshold voltage, is leading to reduction of lifespan (for a given read-out system max
measured Vth 27V). No essential sensitivity degradation (linearity of the response) within
lifespan that can be expanded with increasing of maximum readout Vth by the reader.
Boron implantation under the gate before growing the gate oxide SiO2 has technological
advantage. MOSkin sensitivity did not change as a function of boron dose implantation.
The boron implantation did not boost instability of the threshold voltage in MOSkins used
under positive gate external bias investigation in this work. The most important features
of our MOSkin fabrication technology that boron implantation is essentially reducing
initial Vth (i.e. increasing lifespan of the MOSkin) and spread-out of initial sensitivity is
less than 1%. Last feature is very important as allow prescribe the same sensitivity to the
fabricated batch of the MOSkin using random sampling for calibration.
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Chapter 4 - eXaSkin: a novel high-density bolus for 6 MV Xray radiation therapy
This chapter, is based on material published in Al-Sudani et al. (2019) “Dose build up
characteristics with eXaSkin bolus during 6MV radiotherapy: MOSkin dosimetry results.”
In Journal of Physics: Conference Series (Vol. 1154, No. 1, p. 012024). IOP Publishing., and AlSudani et al. (2020) “eXaSkin: A novel high-density bolus for 6MV X-rays radiotherapy”. Physica
Medica, 80, pp.42-46. These reports discuss the experimental investigations results to evaluate
the potential for using an eXaSkin bolus as an alternative to a Superflab bolus in 6MV
radiotherapy.

4.1 Introduction
In external radiation therapy, calculation of surface and build-up dose is an important issue to
avoid recurrence of a near surface tumour or skin toxicity. The dose at the skin is lower than the
maximum dose by about 25% because of the skin sparing effect (Quach et al. 2000). Head and
neck cancers present many challenges in radiation therapy because of they exist near many critical
structures and there is an irregular contour of this region and planning volumes may need to be
expanded if there is any tumours near surface (Hsu et al., 2008, Luu et al., 2015).
The main factors affecting calculations of surface dose are the beam geometry of incident beams,
electron contamination from the head of the Linac and bolus material (Metcalfe et al., 2012). The
accuracy of dose calculation at surface with a treatment planning system (TPS) is within 20%
(Jong et al., 2016, Fraass et al., 1998, Court et al., 2008, Panettieri et al., 2009, Chakarova et al.,
2012, Akino et al., 2013, Chung et al., 2005).
Boluses are used in radiation therapy to provide a build-up region near the skin, compensate for
irregular surfaces, reduce the depth of maximum dose (dmax) and increase the dose to the surface
depending on the bolus material density (Luu et al., 2015 and Alexander et al., 2019). For
example, the Superflab bolus is commercially used in radiation therapy. It is a synthetic oil gel
based on a vinyl polymer with di-isodecyl phthalate and physical density 1.02 g/cm3. Superflab
is tissue – equivalent with a good flexibility and can create an apparent uniformity of thickness
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when used on irregular surfaces. Yoon et al. (2018) found that the surface dose when using a 6MV
open X-ray field (2000 MUs) without bolus was 51.5±0.8 cGy, whereas with a 1 cm Superflab
bolus 139.3±2.9 cGy surface dose was produced. However, it is often difficult to achieve perfect
contact and conformity with a patient’s skin resulting in air gaps on irregular surfaces causing a
reduction of up to 10% in the surface dose for air gaps larger than 10 mm for 6MV in radiation
fields less than 10x10 cm2 size (Khan et al., 2013, Manger et al., 2016). Given the need for
conformity, the radiation oncologist may seek a more suitable material.
Recently, brass mesh (Manger et al., 2016, Al-Rahbi et al., 2018) was introduced as an alternative
high density bolus to the Superflab bolus. The studies state that the surface dose obtained with
this brass mesh bolus (density = 8.73 g/cm3) were similar to or slightly less than the dose obtained
with a Superflab bolus. The brass mesh bolus with 2 mm thickness does not affect significantly
on depth dose < 0.5%. However, Manger et al reported that brass mesh bolus may be used with
high energy photons (15 MV, 24 MV) but with potential produced photoneutron effective dose to
staff and patients.
This chapter investigated the effect of a novel high-density bolus eXaSkin (manufactured by
Anatomical Geometry, Spain) on skin dose, as an alternative to SuperflabTM bolus. The dose in
the central target volume was studied for head and neck cancer treatment using dual arc VMAT.

4.2 Methodology
4.2.1 The preliminary method
This method was involved calculating the density by measuring the weight and the dimensions of
eXaSkin slabs. It was investigated the dose in the build-up region and the effect of oblique
incident angles for eXaSkin slabs and solid water slabs.
4.2.1.1 Build-up region dose measurements
The eXaSkin bolus (AnatGe, Spain) is a new material (figure 24), which is composed of two
components. Combining the two basic components of eXaSkin produces a new material, which
harden in about two minutes. For build-up measurements, eXaSkin bolus were cuts into 10 x 8
cm2 dimensions with different thicknesses (3, 5, 8, 10 mm). The density of eXaSkin was
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calculated by measuring its slabs dimensions and their weights. The build-up region of eXaSkin
at depths (0, 3, 5, 8, 10, 15 and 26 mm) was compared with the build-up of solid water equivalent
slabs (Gammex, model 457, USA) (Figure 25) at depths (0, 2, 5, 15, 20 and 26 mm) by using an
advanced Markus chamber and MOSkin dosimeters. The advanced Markus chamber dosimeter
was placed inside a groove in a 2 cm solid water equivalent slab and the MOSkin was placed in a
groove in 0.5 cm solid water slab. PDDs were performed with a 6MV Varian Clinac iX (Varian
Medical Systems, Palo Alto, CA) at the ICCC in Wollongong- Australia for irradiated field sizes
of 5 x 5 cm2 and 10 x 10 cm2, with 100 MU doses at 100 cm SSD with 10 cm solid water equivalent
slabs as backscatter material. All the measurements were normalized to dmax and repeated three
times. Rawlinson’s (1992) over-response correction formula for the advanced Markus ionization
chamber was used as in equations 2.1 to 2.3.

Figure 24: eXaSkin material added on top of a solid water-equivalent slab patient “phantom”.

Figure 25: The Solid water-equivalent slab patient “phantom” with inserted ionization chamber.
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4.2.1.2 Effect of Oblique incident beam on the surface
The percentage surface doses (PSD) for different incident angles were measured at the surface
without any bolus and at 3 mm into eXaSkin and solid water-equivalent slabs by using an
advanced Markus chamber and MOSkin dosimeter. The oblique incidence beam was investigated
at 0 º, 15 º, 30 º, 45 º, 60 ºand 75º beam angles for 6 MV 100MU photon beams, 100 SSD and
10x10 cm2 field size. All the measurements were normalized to dmax and repeated three times.

4.2.2 The advanced method
In this method, CT scans were used to calculate the density of the eXaSkin bolus. A STEEV
phantom was used to measure the skin dose when using the VMAT technique.
4.2.2.1 Set-up of bolus materials and planning
A commercial anthropomorphic phantom was used for the study, the Stereotactic End-to-End
Verification Phantom (STEEV; CIRS) (Figure 26). STEEV mimics significant internal anatomy
in the head-and-neck region, such as cortical and trabecular bones, spinal cord, teeth, sinuses, and
trachea.

Figure 26: STEEV phantom. It is composed of three parts with a central cubic volume.
Two types of bolus were used, applied on the left side of STEEV (Figure 27). The first was a 1
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cm uniform thickness piece of commercial Superflab (Med-Tec). Bolus, the second- an eXaSkin
- high-density bolus with adjustable thickness. The eXaSkin was spread onto the side of STEEV
and moulded to the contour shape of the head, neck and torso (see Figure 27).

Figure 27: Left panel: STEEV with SuperflabTM bolus. Right panel: STEEV with eXaSkin bolus.

STEEV was imaged with a Siemens Somatom 64 slice computed tomography (CT) scanner, using
a clinical head and neck protocol with slice thickness of 2 mm each. Scans of the phantom were
performed for three different scenarios: no bolus, Superflab, and eXaSkin. CT images (Figure 28,
29) were transferred to a commercial treatment planning system (TPS), a Pinnacle3 v14; (Philips
Medical Systems); wherein a collapsed cone convolution algorithm was used for dose
calculations. On the CT data set, PTVs were contoured to a central target in the nasopharynx
region, and to a second more superficial region representing neck lymph nodes (Figure 30).
Surrounding organs at risk were also delineated to replicate typically head and neck anatomy.
Planning was performed for using a volumetric modulated arc therapy (VMAT) technique; with
dual coplanar clockwise/counterclockwise arcs, delivered with 6 MV photon flattened beams
produced with a TrueBeam (Varian Medical Systems) medical linear accelerator (linac). A
radiation dose of 70 Gy in 35 fractions was prescribed to the 100% isodose line. 2 Gy per fraction
was delivered to the central target, and 1.8 Gy per fraction was delivered to the lymph node region.
In addition to VMAT, a simple 10x10 cm2 open field at 90° also was applied to verify that the
TPS accurately models the dose downstream of the bolus using a basic beam set-up. This was
particularly important for the eXaSkin with its higher density material.
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Figure 28: Left panel: slice of imported CT scan of STEEV with Superflab bolus on exterior
left face surface. Right panel: slice of imported CT scan of STEEV with eXaSkin. In each
picture, the central circle with “IC” tag indicates ionization chamber location; the labels
“MOSKIN1” and “MOSKIN2” on the righthand side indicate MOSkin locations under the
bolus.

Figure 29: Left panel: coronal slice of imported CT scan of STEEV with Superflab. Right panel:
coronal slice of imported CT scan of STEEV with eXaSkin. In each picture, the central circle
with “IC” label indicates ionization chamber location; to the right, the labels “MOSKIN1”
and “MOSKIN3” indicate MOSkin location under the bolus.
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Figure 30: Left panel: slice of imported CT scan of STEEV with SuperflabTM and the PTV
contoured to a central target in the nasopharynx region. Right panel: slice of imported CT scan
of STEEV with SuperflabTM and PTV were contoured to superficial region representing a neck
lymph node.

4.2.2.2 Measurements
Doses were measured in the central planning target volume (PTV) in the nasopharynx region to
verify TPS modelling at depth, and at the “surface” (immediately under the bolus) to verify dose
calculations in the build-up region. Measurements were performed in each of the three scenarios
(i.e. no bolus, Superflab, eXaSkin), both for the VMAT plan and for the static field.
To measure dose in the central target, we positioned a CC13 ionization chamber (TNC/5597; IBA
Dosimetry) inside STEEV in a dedicated chamber cavity. The ionization chamber had been
previously calibrated under reference conditions to determine an average charge to dose
sensitivity of 26.46 nC/cGy.
To measure surface dose, we placed a MOSkin at each one of the three lymph node sites in the
treated region. The MOSkin is a semiconductor dosimeter developed at the Centre for Medical
Radiation Physics (University of Wollongong, Australia) for measurements of skin dose in
modern radiotherapy (Jamalludin et al., 2019 and Jamalludin et al.,2019); its packaging provides
a highly reproducible water-equivalent depth (WED) of measurement of 0.07 mm, as
recommended by the ICRP for skin dosimetry (Butson et al., 2000). MOSkin dosimeters were
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calibrated at a depth of 1.5 cm, 100 cm source-to-surface distance (SSD), in a solid water
phantom (model 457; Gammex). Irradiations were performed in 10 × 10 cm2 fields produced with
6 MV flattened beams. The calibration factor (CF) was calculated via CF = ∆V/D, where ∆V is
the average threshold voltage shift (in unit mV), and D is the delivered dose (in unit cGy). The
CF of the three MOSkin dosimeters with oxide gate thickness 0.55 µm was 2.24 ± 0.02 mV/cGy.
Before applying the bolus, each MOSkin was placed at locations identified by CT markers on the
left side of STEEV (MOSkin #1, #3), and at 2 cm from MOSkin #1 (MOSkin #2).

4.3 Results
4.3.1 The preliminary method
4.3.1.1 Build-up region dose measurements
The density of eXaSkin was 1.7 ± 0.03 g/cm3 compared with 1.04 g/cm3 for PMMA used in solid
“water-equivalent “phantoms. For the eXaSkin and the solid water-equivalent slabs, Figure 31
show PDD measurement with an advanced Markus chamber and Figure 32 show PDD
measurement with MOSkins, for field sizes of 5 x 5 cm2 and 10 x 10 cm2. The PDD of eXaSkin
for both field sizes was higher than the PDD of solid water in the range 2-10 mm where both were
normalized to dmax.

(a)
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(b)

Figure 31: Build-up region for solid water-equivalent slabs vs eXaSkin slabs measured with an
advanced Markus ionization chamber in (a) 5 x 5 and (b) 10 x 10 cm2 fields at depths in the range
of 0-26 mm.

(a)
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(b)

Figure 32: Build up region for solid water-equivalent slabs vs eXaSkin slabs measured with
MOSkins in (a) 5 x 5 and (b) 10 x 10 cm2 fields at depths in range 0-26 mm.

The dmax of solid water was at 15 mm depth (for bolus of density 1.04 g/ cm3) compared with an
eXaSkin density dmax of 9 mm (1.7 g/ cm3).
The comparison of the PDD of eXaSkin measured by an advanced Markus ionization chamber
measurement and MOSkin dosimeters for both field sizes (5 x 5 and 10 x 10 cm2 see Figure 33)
shows that the large difference between the 2 types of dosimeter is at 0 mm for both field sizes
(7% higher readings from MOSkin dosimeters than ionization chamber readings). This is
attributed to the different in water equivalent depth of measurement (WED of MOSkins being
0.07 mm while the WED of the advanced Markus chamber is 0.045 mm).
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(a)

(b)
Figure 33: PDD of eXaSkin as reported by an advanced Markus ionization chamber and MOSkins
for (a) 5 x 5 cm2 and (b) 10 x 10 cm2 radiation fields.
4.3.1.2 Effect of Oblique incident beam on the patient phantom surface
Figure 34a demonstrates the changes of the percentage surface dose with oblique incident beams
of 6 MV, 100 SSD and 10 x 10 cm2 field size. Advanced Markus measurements and MOSkins
were used. The percentage surface dose increases when the incident beam angle increases because
the charged particle equilibrium CPE shifts near the surface in agreement with the Jong (Jong,
2014) measurements. The measurements of percentage dose with 3 mm of eXaSkin are the highest
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at all angles as shown in Figure 34c and can be compared with the percentage dose at 3 mm depth
in a solid water-equivalent slab (Figure 34b) and at the surface (Figure 34a). The largest difference
in measurements between the advanced Markus chamber and a MOSkinTM dosimeter with 3 mm
eXaSkin was -11% at 75º, attributed to the eXaSkin bolus not covering the entire irradiated
surface (the eXaSkin slab dimensions were 10 x 8 cm2 as noted in Figure 24, but the irradiating
beam is 10 x 10 cm2). There may also be a small effect due to the size and the structure of each
dosimeter.

(a)

(b)
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(c )

Figure 34. The percentage dose for the oblique incident beam by using the advanced Markus
chamber and the MOSkins (a) at the beam entry surface (b) at 3mm depth in Perspx and (c) at
3mm depth in eXaSkin.

4.3.2 The advanced method
The density and thickness of eXaSkin was taken from CT images. Density was estimated to be
1.59 g/cm3, whereas the layer thickness varied between 1.1 cm, 1.0 cm, and 1.2 cm at the position
of MOSkin #1, #2 and #3, respectively. In contrast to Superflab case, there were no air gaps
between the surface of STEEV and the eXaSkin (Figure 28, Figure 29).
In the case of the static field of 10 x 10 cm2, the dose at the central target, as measured with CC13
and as calculated with the TPS, is as shown in Table 5. The measurements in Table 5 are basic
raw results assuming that the TPS is calculating the dose accurately through each type of bolus
and that the radiation transport through the higher density material of the eXaSkin is well
modelled by the TPS. The no bolus ionization chamber measurement provided the reference
scenario, and it can be observed that the results in all three scenarios are almost the same. Dose
to the skin, which is reported in Table 5, was measured with MOSkin #1 and #2 only (MOSkin
#3 was placed outside the 10 x 10 cm2 radiation field and was ignored). The MOSkin
measurements provided a baseline test of the accuracy of the TPS dose calculation beneath the
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bolus materials. In addition, the large difference between measured and TPS reported doses in the
“no bolus” case highlights the inaccuracy of the TPS for calculating dose at the surface of the
skin.
Table 5: Measurements and calculations in 10 x 10 cm2 a static field. Dose at the central target
measured with ionization chamber in three different scenarios: no bolus, Superflab, eXaSkin. Skin
dose at lymph node site #1and site #2 in three different scenarios: no bolus, Superflab, eXaSkin.

Central target
CC13
TPS
% difference
MOSkin #1
TPS
% difference
MOSkin #2
TPS
% difference

Dose (cGy)
No bolus
88.03
86.8
1.4
44.85±0.33
62.4
-28.16
44.06±0.58
59.6
-26.07

Superflab
84.5
83.4
1.3
116.03±1.30
115.7
0.28
117.52±1.70
113.7
3.36

eXaSkin
82.4
81.1
1.6
114.49±1.50
115.9
-1.22
117.29±0.50
116.4
0.76

For VMAT plans, dose at the central target, as measured with CC13 was compared to the dose
calculated with the TPS at a point corresponding to the central axis of the ionization chamber
(Table 6). Measured and calculated dose to the skin for the same plans is provided in Table 6.
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Table 6: VMAT plan measurements and calculations. Dose at the central target in three different
scenarios: no bolus, Superflab, eXaSkin. Skin dose at lymph node site #1, #2 and site #3 in three
different scenarios: no bolus, Superflab, eXaSkin.

CC13
TPS

Dose (cGy)
No bolus
201.4
202.8

Superflab
202.2
201.4

eXaSkin
197
198.8

% difference

-0.7

0.4

-0.9

MOSkin #1
TPS

32.21±0.00
32.59

61.76±1.98
55.31

70.81±2.50
69.51

% difference

-1.17

11.66

1.87

MOSkin #2
TPS

41.05±1.98
39.94

63.16±0.00
59.51

76.24±0.00
74.05

% difference

2.78

6.13

2.96

MOSkin #3
TPS

116.19±0.32
116.22

166.12±4.00
161.34

167.91±1.98
158.88

% difference

-0.03

2.96

5.68

Central target

In all scenarios, the measurements with MOSkin and CC13 were repeated three times. As can be
observed in Table 6, there is a high standard error (4%) with MOSkin#3 and Superflab bolus
during the VMAT plan. The standard error For CC13 is zero.

4.4 Discussion
Skin dose assessment with an eXaSkin bolus is essential to ensure dose delivery to near- surface
tumors without producing excessive skin reaction. According to the manufacturer, eXaSkin has a
density of 1.53 g/cm3. In the classic method, the density of eXaSkin material was calculated by
measuring its slab’s dimensions and their weights was 1.7± 0.03 g/cm3. In the advanced method,
the density based on CT-scanned images was estimated to be 1.59 g/cm3. This is consistent with
that stated by the manufacturer (1.53 g/cm3), within +/-3.4%.
In the classic method, the eXaSkin bolus delivered high dose at depth 2-10 mm and a high dose
to the skin at high angles in range 0°-75° compared with the plain solid water-equivalent slab
phantom.
68

In the advanced method, the eXaSkin demonstrated superior adaptation to the skin surface,
producing minimal air gaps, allowing for accurate positioning and reproducibility of set-up
conditions. On CT images, some small air bubbles are observed inside the eXaSkin bolus (see
Figure 29 right panel); this can be prevented by more firmly pressing the bolus material, which is
flexible. Also, the layer of eXaSkin was observed to be slightly non-uniform: its thickness varied
in the range from 1.0 cm and 1.2 cm, as measured at the position of each MOSkin. However, if
eXaSkin is placed before acquiring the planning CT image, its exact density, shape and thickness
can be taken into account by the TPS using the CT data.
Dose was first assessed at the central target and at the surface using a 6 MV static field of 10.0 x
10.0 cm2. In all scenarios (no bolus, Superflab, eXaSkin), dose at the central target, as measured
by CC13, was slightly higher than that calculated by the TPS, but agreeing to within 1.6%. Skin
dose measured at the lymph node sites #1 and #2 showed differences with TPS calculations as
large as 28% when no bolus was used. This significant variation was expected, because the TPS
is known to be generally less accurate (within 20%) in the build‐up region (Fraass et al., 1998,
Court et al., 2008, Panettieri et al., 2009, Akino et al., 2012 and Chakarova et al., 2012). With the
added build-up provided by bolus, measurement and calculations of skin dose agreed to within
1.22%.
In our second round of measurements, we assessed dose at the central target and at the surface
during VMAT delivery. In all scenarios, dose measured at the central target and calculations with
the TPS agreed to within 1%. Skin dose at lymph node sites #1 to #3 was higher when bolus was
used, as expected because of added build-up. A notable observation was that, in the VMAT
delivery, the measured skin dose had a better agreement with calculations in the “no bolus”
scenario. This can be explained by considering that, during arc deliveries, a more significant
portion of the dose to the skin is scattered within the phantom and a less significant portion is
produced by build-up.
For the VMAT plan, MOSkin results for the VMAT plans showed agreement with the TPS
underneath the eXaSkin to between 2-6%. The dose at the skin underneath the Superflab showed
larger variation, likely due to the poor adherence to the “skin” surface and difficulties in
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reproducing the position of the bolus from CT imaging to linac measurement. The consequence
of larger air gaps on the surface depends on multiple parameters (beam energy, radiation field
size, and angle of incidence). An air gap of 1 cm between Superflab and skin produced a
significant error, but this became insignificant for fields of 10 × 10 cm2 or larger (Khan et al.,
2013). Errors become more important with increasing adoption of highly conformal techniques,
which use small field apertures and multiple beams from different angles.

4.5 Conclusions
In this chapter, eXaSkin, a novel high-density bolus for megavoltage radiotherapy, was shown to
have many favorable characteristics over the Superflab bolus such as: superior adaptation to the
skin surface, producing minimal air gaps or bubbles, allowing for accurate positioning and
reproducibility of set-up conditions. Measurement of dose underneath the bolus showed good
agreement with the TPS calculations, indicating the higher density material was accurately
modelled within the TPS. Overall, we conclude that the eXaSkin bolus is a viable option to treat
tumours near the surface.
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Part 2 – The Octa dosimeter
The Octa is a 2D monolithic silicon array dosimeter. It was designed at the CMRP at
University of Wollongong, Australia. The Octa based on a high resistivity p-silicon
substrate epitaxial grown on top of a low resistivity p+ substrate. It has 512 strip-SVs
spread out along four intersecting orthogonal linear arrays oriented 45° with respect to
each other. All the SVs have the same area of 0.032 mm2 with a rectangular shape
dimensions of 0.04 mm wide and 0.80 mm length except the nine central pixels which
have dimensions of 0.16 mm wide and 0.20 mm length. The total dimensions of the Octa
is a 38.7 mm wide and 38.7 mm length with 0.3 mm pitch for vertical and horizontal
arrays and 0.43 mm pitch for diagonal arrays (Figure 35a). Furthermore, adding a small
air gap on top of the SVs to maintain correction factors close to unity. The Octa is covered
by an epoxy resin with a 0.10 mm thickness to protect it against moisture and accidental
damage. The Octa is placed between two Perspex plates with a 5 mm thickness each
(Figure 35 b). It is wire bonded to a 0.5 mm thick of printed circuit board (PCB) for
connection to a multichannel read-out data acquisition (DAQ) system (Figure 35c). The
DAQ is based on a field- programmable gate array (FPGA) Xilinx Spartan 3, four
analogue to digital converters (ADC) and eight analogue front-end (AFE) AFE0064
(Texas Instruments) chips (Biasi 2019). The Octa is operated in passive mode (no bias
voltage applied) and connected to DAQ. The epitaxial Octa is describing as the epitaxial
layer is doped by adding a gaseous boron compounds to the environment leads to boron
diffuses into the layer
The Octa graphical user interface (GUI) software is used for real time visualization. When
the FPGA connects to the PC, the GUI is turn on and the user can load the firmware in
the FPGA (Figure 36)
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(a)

(b)

(c )
Figure 35: The Octa dosimeter system. (a) The four arrays of the Octa (b) The Octa dosimeter
between two plates (c) The Octa Data acquisition system (DAQ) (Biasi 2019) consists of 1-four
boards (from left) with 2 AFEAs each 2- plastic case containing the FPGA and associated
circuits with three ports for: i) USB link for data transmission to or from PC. ii) the power
supply. iii) the coaxial cable for linac trigger signal acquisition.

Figure 36: Snapshot of the Octa graphical user interface
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Chapter 5 – Design of a custom-made phantom for using the
Octa to ensure the quality of stereotactic body radiation
therapy for vertebral metastases
This chapter presents a custom-made phantom for using the Octa to ensure the quality of
stereotactic body radiation therapy (SBRT) for vertebral metastases. The phantom was
designed so that the Octa array can be set in a position parallel to the incident radiation
beam, to measure dose distributions in a horizontal plane (Figure 37). The goal of SBRT
for vertebral metastases is to deliver a high dose to the tumour in the vertebral bones,
using small radiation beams, while sparing the spinal cord.

Figure 37. Illustration and naming of the main human anatomical planes (top, a, b, c) and views
of the human L3 vertebra (bottom images a, b, c) from a viewpoint normal to the same three
anatomical planes respectively (Busscher et al., 2010). The position of the dosimeter to integrate
into the phantom is centred on the L3 (lumber) vertebra and parallel with or in the horizontal
plane shown (c).
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5.1 Introduction
Quality assurance (QA) procedures are essential for reducing the risk of errors in radiation
therapy. QA includes pre-treatment verification of patient plans, to ensure the delivered
dose in the relevant plan matches the dose calculated by the treatment planning system
(TPS). Low et al (Low et al., 2010) introduced different dosimetric QA techniques to
verify plans. A method for QA is to compare between calculated and measured doses
using indirect dose verification with a patient specific dosimetric phantom (Oh et al.,
2017).
SBRT for vertebral metastases delivers high dose to a small target area, using small
radiation beams, with steep dose gradients in the delivered dose distribution. Hence, the
QA necessitates an accurate dosimeter for small fields (Kim et al., 2017).
Recently, to verify dose distributions in radiation therapy, various types of 3D printing
technologies are used to manufacture spine phantoms (Oh et al., 2017, Kim et al., 2017,
Tino et al., 2019) and various types of monolithic silicon array dosimeters have been
manufactured with small sensitive volumes and sub-millimeter pitch, used for 2D dose
mapping in small radiation fields (Biasi et al., 2019)
The aim of this chapter is to describe the custom-made design of a phantom designed to
lodge the novel 2D monolithic silicon array dosimeter, the Octa, for QA of SBRT for
vertebral metastases.

5.2 Methodology
In the present study, we report the manufacturing procedures for the phantom via the
assistance of computer-aided design (CAD) technology (version 2014, Autodesk Inc.).
The phantom was fabricated from poly-methyl-methacrylate (PMMA) with an arch
shape. It manufactured in the University of Wollongong workshop and it consists of two
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separate plates (Figure 38a), a front plate (Figure 38b), and a back plate (Figure 39). The
front plate contains the air gap which protects the Octa and optimizes its response for
small fields (Stansook et al.,2017). Figure 40 illustrates the dimensions of the print circuit
board of the Octa to lodged it between the spine plates.

Figure 38. Side view of the PMMA spine phantom showing thickness dimension when using two
component planes (100.50 mm) and when using only the front plane (50.50 mm), both
configurations including the base of the phantom.

( 1)

(2)

Figure 39. Back view for the PMMA spine phantom for the back plane (1) shows the width of the
whole back plane (216mm) (2) shows the distance from the top to the center of the air gap in the
phantom (123 mm).
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(a)

(b)

( c)

Figure 40. The dimensions of the printed circuit board (PCB) of the Octa, which is sandwiched
between the front plane and the back plane of the spine phantom according to the air gap. (a)
the distance from the top of the phantom to the center of the air gap of the phantom is 123 mm.
(b) the width of the Octa PCB is 173 mm (c) the distance from the top of the rectangular shape
to the center of the air gap.

5.3 Results and discussion
Vertebral metastases are tumours developing within the bones of the spine (Tseng et al.,
2017). Radiation therapy is the most common method to successfully treat these tumours
through a modality such as SBRT (Lee et al., 2019). For QA in this context, a custommade phantom of PMMA was manufactured. This allowed for fulfilling the requirements
for suitable QA of treatment plans by allowing measurement of the absorbed dose and
dose distribution penumbra (Chung et al., 2018).
The custom-made phantom was constructed from two plates in an arch shape. The Octa
can be located inside the phantom. The thickness of both plate is 100.50 mm which is
50.5 mm for the front plate with an air gap.
SBRT for vertebral metastases delivers high dose to the target and use a small radiation
fields with a steep dose gradient at the edges of the dose distribution to avoid the spinal
cord itself with the delivered dose distribution (Kim et al., 2017) (Figure 41). The
common method to QA the treatment is to measure the dose distribution in the relevant
treatment area, most commonly using a dosimeter in the frontal (coronal) plane or sagittal
plane (Figure 37), but what we need is to measure the dose distribution in the transverse
(horizontal) plane (Figure 37).
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(a)

(b)

(c)

Figure 41. Isodose distribution of three-dimensional conformal radiotherapy for vertebral
metastasis in different planes: a) frontal plane b) sagittal plane c) horizontal plane (Lee et al.,
2019).

The Octa in the custom-made phantom can be used to measure the delivered dose
distribution in the horizontal plan of the “tumour” region (Figure 42, Figure 43). The Octa
dimension are 38.7 x 38.7 mm and the diameter of the spinal cord region is 10-15 mm.
Hence, the Octa can measure the dose to the spinal cord and to an appreciable extent of
surrounding area containing the tumour.

Figure 42. Schematic diagram of the custom-made phantom using CAD
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Figure 43. Photograph of the Octa in the custom-made phantom.

5.4 Conclusion
A custom-made phantom for the Octa, with the aim of applications for quality assurance
of SBRT for vertebral metastases was manufactured.
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Chapter 6 - The angular dependence of the OCTA in a
cylindrical phantom in the case of 6 MV X- rays radiation
therapy
6.1 Introduction
Recently, 2-D monolithic silicon array dosimeters have been used to ensure the quality of
radiation therapy. One of the limitations of these dosimeters is that their sensitivity varies
as a function beams of radiation beams’ angle of incidence. This is important when the
dosimeter is used for measurements during arc deliveries, for instance VMAT, as the linac
gantry rotates during delivery.
The angularly dependent sensitivity of a monolithic silicon array depends on the
materials of the dosimeter sensitive volume (SV) as well as on the materials and volume
of their packaging (Stansook et al., 2017). All these components perturb, to various
degree, the secondary electron spectrum as a function of radiation’s incident angle.
In this chapter, the angularly dependent sensitivity of the Octa inside a cylindrical
phantom of solid water was investigated according to a procedure detailed by Stansook
(Stansook et al., 2017). EBT3 Gafchromic films were used as a benchmark.

6.2 Methodology
To study the angularly dependent sensitivity of the Octa, the Octa was inserted into the
DosePoint (DosePoint GmBH, Wiesloch, Germany) RT-smartIMRT RW3-based
cylindrical phantom of 30 cm diameter (Figure 44). The Octa was set in a cylindrical
phantom in a vertical position to avoid the treatment coach, with its main receiving
surface perpendicular to the incident beam and the 0 angle is identified as the horizontal
position of the gantry (as shown in Figure 45). The central diode of the Octa was aligned

79

to the machine isocentre.

Figure 44. Snapshot of the Octa in the DosePoint RT-smartIMRT cylindrical phantom

Figure 45. The Octa in a vertical orientation with respect to the linac.

The radiation beams were generated by a Varian Clinac iX linac (Varian Medical System,
Palo Alto, CA) equipped with a 120 Multi-Leaf Collimator (MLC) at the Illawarra Cancer
Care Centre. The Octa was irradiated with 6 MV beams and measurements were taken
for fields 10 x 10 cm2, 2x2 cm2 and 1x1 cm2. The gantry was rotated in a clockwise
direction from 0° to 180° in steps 15° for the 10 x 10 cm2 field and in steps of 45° for the
2 x 2 and 1 x 1 cm2 fields.
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EBT3 films were used as a reference dosimeter to investigate the angular response of the
Octa, and these were irradiated with the same beam used for the Octa. EBT3 films were
cut into 4 x 4 cm2 squares and placed in the position of the Octa dosimeter in the
cylindrical phantom. The films were scanned six times at the same position in the center
of an EPSON scanner with a spatial resolution of 72 dpi. The last three scans were used
for analysis the data to ensure thermal stability and consistency of the scanner. The
ImageJ (National Institute of Health, USA) software package and Microsoft Excel 2016
were used for data analysis.
According to the procedure by Stansook et al. (Stansook et al., 2017), the calibration
factors (a) were calculated from the ratio of the Octa response to the EBT3 response as a
function of gantry angle Ɵ.
a (Ɵ) =

𝑂𝑐𝑡𝑎(𝜃)

---------------(6.1)

𝐸𝐵𝑇3(𝜃)

For a given field size, the angular response ((C (Ɵ)) was the ratio of the calibration factor
at any angle Ɵ to the calibration factor at 0°
C (Ɵ) =

𝑎(𝜃)
𝑎(00 )

-----------------(6.2)

For correction the response in small fields for any angle, the dose map measured by the
Octa ((Octa corrected (Ɵ)) was obtained by dividing the Octa response of the small square
field ((Octa’ (Ɵ)) by the angular response C (Ɵ) of the large square field 10x10 cm2.
Octa corrected (Ɵ) =

𝑂𝑐𝑡𝑎′ (𝜃)
𝐶(𝜃)

----------------- (6.3)

The study of the angular dependence for the Octa was expanded to include both the nine
central pixels and all the remaining pixels in all of the arrays of the Octa. The correction
factors calculated from the large square field 10x10 cm2 for 6MV energy photon beams
were used to correct the angular response of the small square fields. In terms of the beam
profile and penumbra measurements, all the angular correction factors of the Octa have
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been calculated to improve the accuracy of the measured small field dose map.

The angular relative response of the Octa was calculated for the nine central SVs for all
given fields and for all the pixels of the Octa for the large field size 10 x 10 cm2. To show
the effect of field size on the angular dependent response, the P-value of chi square test
was used to compare the angular response for the same angles for different field sizes.
The GEANT4 Monte Carlo toolkit was used to calculate the angular response of the nine
central pixels of the Octa inside the cylindrical phantom. As in experimental set up, the
Octa dosimeter was placed perpendicular to the incident beam inside the cylindrical
phantom. The comparison between the GEANT4 calculation for the average of the
angular responses of the nine central pixels and the experimental results was achieved.
For any simulation in radiotherapy application, the Geant4 classes which must be
involved to customize the materials geometry, quantities of particles and physics models
that must be tracked at any interaction are:
The G4VUserDetectorConstruction class, defines the materials, the geometries of these
materials and their spatial positions such as the detectors and targets.
The G4VUserPrimaryGeneratorAction class, defines the incident primary particles such
as the particles type and their energy.
The G4VUserPhysicsList class, defines the physics models and cross sections for any
given simulation. There are many physics models the user can use the appropriate one for
candidate simulation and three methods which can be implemented involved the
Construct-particle method, the Construct process method and Set-Cut method. The
particles which generated for simulation need to define the relevant particles, interaction
models and the cut value to be applied that will not be tracked and stopped its deposit
energy.
The G4VUserStepperAction class, used to implement the methods and to execute them
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at the end of each step. A step in Geant4 characterizes the transport of a particle between
two points in space. A track is a snapshot of physic quantities of particle at a point along
its path and a trajectory is a collection of tracks a long its path. The software Root (RootData Analysis Framework) was used for data analysis to compare between the
experimental results and the Geant4 simulation results.

6.3 Results and discussion
Figure 46 illustrates the angular response of the Octa for 6 MV beams as a function of the
incidence angle between 0° and 180°. The angular response was calculated from the
average of the nine central diodes. For the 10 x 10 cm2 and for the 2 x 2 cm2, response is
normalized to 0° gantry angle in Figure 46a, and for the 10 x 10 cm2, 2x 2 cm2 and 1x1
cm2 response is normalized to 180° gantry angle in Figure 46b. This is because the
irradiation of the EBT3 film for radiation incident angle 0 was lost for field size 1 x 1 cm2
after the experiment.
In the small fields incidence angles of 45°, 90°, 135° and 180°were selected to show the
effect of the small fields’ sizes on the angular response of the Octa compared with the
angular response of the large field.
Figure 46 shows that for all the field sizes, the angular response of the Octa decreases as
the incident beam angle increases from 0° to 90° with a minimum response at incidence
angle 90° when the beam direction was parallel to the Octa plane and after 90° the
response increases. At 90°, the minimum angular response is 0.79 for 10 x 10 cm2, 0.85
for 2 x 2 cm2 (Figure 46a). The error bars for the angular response in the 10 x 10 cm2
showed a maximum standard deviation of 3% at 30° and in 2 x 2 cm2 showed a maximum
standard deviation of 2% (not visible in Figure 46a because small compared to symbol
size).
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(a)

(b)

Figure 46: The averaged angular response of the nine central pixels of the Octa as a function of
the incident beam angle for 6MV with 10 x 10 cm2, 2 x 2 cm2 and 1x1 cm2 fields. (a) The angular
response of the 10 x 10 cm2 and 2 x 2 cm2 are normalized to 0° (b) and 1x1, 2x2, 10x10 cm2 are
normalized to 180°.
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The results for the angular response of the Octa for all the fields used are in agreement
with those of a previous angular response investigation of MP512 (Stansook et al., 2017)
and Octa (Biasi et al., 2019) at all angles except at 90°.
The comparison between the angular response for different field sizes at different
incidence angles was achieved by calculating the P-value of chi-square for the same
angles. There was no significant difference in the angular response between the field sizes
10 x 10 cm2 and 2 x 2 cm2 where the P-value was 0.9991 or between the field sizes 10 x
10 cm2 and 1 x 1 cm2 where the P-value was 0.9998. The results show agreement with
the Stansook et al results where there was also no significant difference noted between
the different field sizes. Therefore, the angular response correction factors of the field size
10 x 10 cm2 can also be applied to the small fields of 2 x 2 and 1 x 1 cm2.
Figures 47-50 illustrates the angular relative response for each pixel in the Octa array
(Vertical, Horizontal, North West South East (NWSE), and South West North East
(SWNE)) at incident angles between 0° and 180° steps in 15° for the 10 x 10 cm2 field.
The fluctuation in the response attributes either to the functioning of each pixel in this
experiment or to the fluctuation in the EBT3 films data. In the EBT3 films analysis, we
did not use any filter to smooth the beam profile and the interpolation was used to
calculate the angular response.
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Figure 47: The angular response for each pixel of the Octa arrays as a function of the incident
beam angle for 6MV with 10 x 10 cm2 FS for vertical, (b)horizontal, (c)NWSE and (d)SWNE
arrays.

Figure 48. The angular response for each pixel of the Octa arrays as a function of the
incident beam angle for 6 MV with 10 x 10 cm2 FS for horizontal, arrays.
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Figure 49. The angular response for each pixel of the Octa arrays as a function of the incident
beam angle for 6MV with 10 x 10 cm2 FS for NWSE arrays.

Figure 50. The angular response for each pixel of the Octa arrays as a function of the

incident beam angle for 6MV with 10 x 10 cm2 FS for SWNE arrays.
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The incident radiation beam at 0° gantry angle was set to face the silicon wafer surface in
the area of the central diode of the Octa. Between 0° and 90° gantry angles, the incident
radiation beam needs to go through a longer path of silicon to reach the same central
diode. The path of radiation through the silicon is 0.47 mm when at 180° gantry angle
and 19 mm when at 90° gantry angle. So, the higher attenuation occurred when the beam
passing through the silicon substrate and the perturbation that accompanied the lateral
equilibrium and scattered secondary electrons is from the silicon substrate and from the
air gap that surrounds the silicon substrate (Stansook et al., 2017 and Biasi et al., 2019).
Between 90° and 180° gantry angle, the incident radiation beam was traversing the silicon
wafer and the printed circuit board (PCB) to which the dosimeter wires are bonded (Biasi
et al., 2019).
Figure 51 illustrates the angular response of the nine central pixels of the Octa and Figure
52 compares the average of the angular response of the nine central pixels and the
GEANT4 simulation.

Figure 51. GEANT4 calculation of the angular response coefficients for the nine central sensitive
volumes of the Octa inside the cylindrical phantom. (12,12) represent the central pixel.
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Figure 52: The average of the angular response coefficients for the nine central sensitive volumes
of the Octa computed by the GEANT4 compared with experimental results.

There was a good agreement between the GEANT4 and experimental results for the
angular response of the Octa at different incidence angles. The small difference at 75° and
105° occur because of the incidence particles traversing the through a long length of PCB
in the experimental set up, which was not allowed for the GEANT4 simulation because
there was no accurate information on PCB composition.
To investigate the validity of the angular correction factors of the 10 x 10 cm2 field for
smaller fields, the beam profiles and penumbra measurements were achieved as
following:
The beam profiles for the 2 x 2 cm2 small fields were measured using the Octa at incidence
angles from 0° angle to 180° angle in steps of 45°. The same beam profiles were also
measured with EBT3 films, reproducing the same experimental conditions.
The comparison between the beam profiles measured with the Octa and those measured
with EBT3 films was achieved by comparing the full width of half maximum (FWHM)
and (20%-80% max intensity) penumbra width. The difference in the FWHM between
the Octa and EBT3 films was calculated in accordance with the following function:
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% Difference in FWHM =

𝑂𝑐𝑡𝑎−𝐸𝐵𝑇3
𝐸𝐵𝑇3

× 100………….…..(6.4)

In tables 7-10, the comparison of beam profiles for 2 x 2 cm2 field size between the EBT3
film and the Octa uncorrected at 0° angle shows the dose profile of the EBT3 film is wider
than the Octa measurements. There is a lateral shift in the axes of the dose profile of the
film, attributed to the position of the film during the experiment. However, the FWHM
and (20%-80%) penumbra measurements from the EBT3 and Octa agree within ±0.5%
and 0.5 mm, respectively. The Octa uncorrected response shows a slight dose profile
distortion compared with the EBT3 film results. To correct the Octa data, the angular
response correction factors for 10 x 10 cm2 field size were applied. After this correction
is made, Tables 7-10 show a good improvement in the estimates of the FWHM and (20%80%) penumbra width from 3.5% and 1.30 mm to within 1 % and 1 mm for orthogonal
arrays and from 3.3% and 1.7 mm to within 2% and 1.4 mm for diagonal arrays,
respectively.
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Table 7. FWHM and the (20%-80%) penumbra width difference for 2 x 2 cm2 field size at 6 MV
between the EBT3 films and the Octa dosimeter before and after the large field size correction is
applied for Vertical array of Octa.

angle
0

45

90

135

180

VERTICAL
Diff
R.Penumbra
%
(mm)
3.85
-0.18
3.40

EBT3 film
Octa uncorrected

FWHM
(mm)
19.94
19.90

EBT3 film
Octa uncorrected
Octa corrected

20.30
19.50
20.10

-3.94
-0.99

EBT3 film
Octa uncorrected
Octa corrected

19.70
19.80
19.70

EBT3 film
Octa uncorrected
Octa corrected
EBT3 film
Octa uncorrected
Octa corrected

Diff
(mm)
-0.45

L.Penumbra
(mm)
3.85
3.40

Diff
(mm)

3.85
3.00
3.30

-0.85
-0.55

3.85
2.70
3.15

-1.15
-0.70

0.51
0.00

3.00
3.40
2.40

0.40
-0.60

2.00
3.00
2.80

1.00
0.80

19.95
19.80
19.95

-0.75
0.00

3.10
1.95
2.30

-1.15
-0.80

3.60
2.70
2.85

-0.90
-0.75

20.30
20.20
20.30

-0.49
0.00

3.50
2.70
3.00

-0.80
-0.50

3.70
2.50
2.60

-1.20
-1.10

-0.45

Table 8. FWHM and the (20%-80%) penumbra width difference for 2x2 cm2 field size at 6MV
between the EBT3 films and the Octa dosimeter before and after the large field size correction
is applied for Horizontal array of Octa.

angle
0

45

135

180

EBT3 film
Octa uncorrected

HORIZONTAL
FWHM
Diff
R.Penumbra
(mm)
%
(mm)
20.30
3.15
20.40
0.49
2.85

Diff
(mm)
-0.30

L.Penumbra
(mm)
3.50
3.20

Diff
(mm)
-0.30

EBT3 film
Octa uncorrected
Octa corrected

28.35
28.20
28.35

-0.53
0.00

3.85
3.30
3.45

-0.55
-0.40

4.73
4.35
4.65

-0.37
-0.07

EBT3 film
Octa uncorrected
Octa corrected

28.35
28.20
28.35

-0.53
0.00

3.68
2.70
3.10

-0.98
-0.58

4.90
3.60
3.80

-1.30
-1.10

EBT3 film
Octa uncorrected
Octa corrected

20.30
20.10
20.30

-0.99
0.00

2.98
2.30
2.70

-0.68
-0.27

3.15
2.40
2.40

-0.75
-0.75
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Table 9. FWHM and the (20%-80%) penumbra width difference for 2x2 cm2 field size at 6MV
between the EBT3 films and the Octa dosimeter before and after the large field size correction
is applied for NWSE array of Octa.

0

45

90

135

180

NWSE
Diff
%

-0.20

-1.13
-0.92

5.00
4.73
4.95

-0.27
-0.05

1.36
0.00

4.70
3.66
4.40

-1.05
-0.30

6.20
4.95
5.32

-1.26
-0.88

2.05
0.00

3.85
3.44
3.75

-0.41
-0.10

6.00
4.30
4.58

-1.70
-1.42

-0.08
0.00

4.00
3.44
3.86

-0.56
-0.14

4.00
3.23
3.60

-0.78
-0.40

-0.38

-0.83
-0.05

5.00
3.87
4.09

28.00
28.38
28.00

EBT3 film
Octa uncorrected
Octa corrected

27.60
28.17
27.60

EBT3 film
Octa uncorrected
Octa corrected

26.25
26.23
26.25

EBT3 film
Octa uncorrected
EBT3 film
Octa uncorrected
Octa corrected

27.75
27.52
27.74

EBT3 film
Octa uncorrected
Octa corrected

Diff
(mm)

L.Penumbra
(mm)
4.50
4.40

R.Penumbra
(mm)
3.00
2.80

FWHM
(mm)
26.50
26.40

angle

Diff
(mm)

-0.10

Table 10. FWHM and the (20%-80%) penumbra width difference for 2x2 cm2 field size at 6MV
between the EBT3 films and the Octa dosimeter before and after the large field size correction is
applied for SWNE array of Octa.

angle
0

45

90

135

180

SWNE
Diff
R.Penumbra
%
(mm)
4.00
-0.38
3.90

EBT3 film
Octa uncorrected

FWHM
(mm)
26.50
26.40

EBT3 film
Octa uncorrected
Octa corrected

27.50
27.09
27.52

-1.49
0.07

EBT3 film
Octa uncorrected
Octa corrected

28.45
27.95
28.30

EBT3 film
Octa uncorrected
Octa corrected
EBT3 film
Octa uncorrected
Octa corrected

-0.10

L.Penumbra
(mm)
4.00
3.80

5.00
3.66
5.00

-1.35
0.00

5.25
4.30
4.30

-0.95
-0.95

-1.76
-0.53

4.10
3.00
3.96

-1.10
-0.14

5.00
5.16
4.99

0.16
-0.01

27.50
27.95
27.75

1.64
0.89

4.00
3.44
3.70

-0.56
-0.30

4.70
3.90
4.21

-0.80
-0.49

26.50
25.62
25.90

-3.32
-2.26

4.00
3.23
3.44

-0.78
-0.56

3.50
3.23
3.40

-0.28
-0.10
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Diff
(mm)

Diff
(mm)
-0.20

For field size 1 x 1 cm2, the beam profiles of the Octa uncorrected at 45°, 90°, 135° and
180° in terms of the full width of half maximum (FWHM) and (20%- 80%) penumbra
width show a distortion with respect to the EBT3 films responses as detailed in Tables
11-14. The slight lateral shift in the axis of the dose profiles between the Octa dose
profiles and the EBT3 dose profiles is because of the position of the films during the
experiment. The dose beam profiles of the EBT3 films are wider than the Octa dose
profile for all angles. There are no beam profiles for 1 x 1 cm2 field size at 0° angle
because it was lost in the hospital during the experiment. There are 11% and 2 mm
discrepancy between Octa uncorrected and EBT3 film results, respectively in FWHM and
the (20%-80%) penumbra width for orthogonal arrays and within 10% and 1 mm for
diagonal arrays. A good improvement in the FWHM and (20%-80%) penumbra width is
gained after applying the 10x10 cm2 field size correction factors as in Tables 11-14.
FWHM and the (20%-80%) penumbra width after the correction is applied are within 8%
and 1.5 mm for orthogonal arrays and within 8% and 1 mm for diagonal arrays,
respectively.
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Table 11. FWHM and the (20%-80%) penumbra width for the EBT3 films for the Vertical array
of Octa measurements before and after applying the correction factors of field size 10 x 10 cm2
with the differences for 1 x 1cm2 field size all at 6MV.

EBT3 film
Octa uncorrected
Octa corrected

FWHM
(mm)
9.70
8.85
9.00

EBT3 film
Octa uncorrected
Octa corrected

9.80
8.70
9.00

EBT3 film
Octa uncorrected
Octa corrected

9.80
9.30
9.50

EBT3 film
Octa uncorrected
Octa corrected

10.15
9.90
10.00

angle
45

90

135

180

VERTICAL
R.Penumbra
Diff
(mm)
%
2.90
2.40
-8.76
2.60
-7.22

-11.22
-8.16

2.80
2.25
2.40

-5.10
-3.06

2.63
2.10
2.30

-2.46
-1.48

2.80
2.10
2.50

Diff L.Penumbra
(mm)
(mm)
2.90
2.00
-0.50
2.80
-0.30

Diff
(mm)
-0.90
-0.10

-0.55
-0.40

2.80
2.25
2.25

-0.55
-0.55

-0.53
-0.33

2.45
2.10
2.40

-0.35
-0.05

-0.70
-0.30

2.80
2.20
2.20

-0.60
-0.60

Table 12. FWHM and the (20%-80%) penumbra width for the EBT3 films for the Horizontal
array of Octa measurements before and after applying the correction factors of field size 10 x
10 cm2 with the differences for 1 x 1cm2 field size all at 6MV.

angle
45

135

180

EBT3 film
Octa uncorrected
Octa corrected

FWHM
(mm)
14.70
14.10
14.30

EBT3 film
Octa uncorrected
Octa corrected

14.35
14.10
14.20

EBT3 film
Octa uncorrected
Octa corrected

10.50
9.90
10.00

HORIZONTAL
R.Penumbra
(mm)
4.00
-4.08
2.40
-2.72
2.70
Diff
%

-1.74
-1.05

3.15
2.40
3.00

-5.71
-4.76

2.28
1.95
2.10
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Diff
(mm)
-1.60
-1.30

L.Penumbra
(mm)
4.25
2.40
2.80

Diff
(mm)

-0.75
-0.15

3.50
2.40
2.70

-1.10
-0.80

-0.32
-0.18

2.45
2.10
2.20

-0.35
-0.25

-1.85
-1.45

Table 13. FWHM and the (20%-80%) penumbra width for the EBT3 films for the NWSE array
of Octa measurements before and after applying the correction factors of field size 10 x 10 cm2
with the differences for 1 x 1cm2 field size all at 6 MV.

EBT3 film
Octa uncorrected
Octa corrected

FWHM
(mm)
13.50
12.40
12.80

EBT3 film
Octa uncorrected
Octa corrected

13.50
12.69
12.80

EBT3 film
Octa uncorrected
Octa corrected

13.50
12.90
13.20

EBT3 film
Octa uncorrected
Octa corrected

13.50
12.04
12.40

angle
45

90

135

180

NWSE
R.Penumbra
Diff
(mm)
%
3.50
3.23
-8.15
3.50
-8.16

Diff
(mm)

-0.28
0.00

L.Penumbra
(mm)
4.00
3.01
3.80

-6.04
-5.19

3.75
3.44
3.70

-0.31
-0.05

3.75
3.23
3.70

-0.52
-0.05

-4.44
-2.22

3.50
3.44
3.50

-0.06
0.00

4.00
2.96
3.50

-1.04
-0.50

-10.81
-8.15

3.50
2.80
2.91

-0.71
-0.59

3.50
2.80
3.00

-0.71
-0.50

Diff
(mm)

-0.99
-0.20

Table 14. FWHM and the (20%-80%) penumbra width for the EBT3 films for the SWNE array
of Octa measurements before and after applying the correction factors of field size 10 x 10 cm2
with the differences for 1 x 1cm2 field size all at 6MV.

angle
45

90

135

180

EBT3 film
Octa uncorrected
Octa corrected

FWHM
(mm)
13.00
12.04
12.80

EBT3 film
Octa uncorrected
Octa corrected

13.75
12.26
12.90

EBT3 film
Octa uncorrected
Octa corrected

13.50
12.90
13.20

EBT3 film
Octa uncorrected
Octa corrected

13.00
11.83
11.90

SWNE
Diff
%
-7.38
-1.54

R.Penumbra
(mm)
3.50
3.44
3.50

-10.87
-6.18

3.75
3.01
3.23

-4.44
-2.22

3.50
3.01
3.25

-9.04
-8.46

3.00
2.80
2.97
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Diff
(mm)
-0.06
0.00

L.Penumbra
(mm)
3.75
3.44
3.70

Diff
(mm)

-0.74
-0.53

4.25
3.23
3.44

-1.03
-0.81

-0.49
-0.25

3.25
3.23
3.25

-0.03
0.00

-0.21
-0.03

3.00
2.37
3.00

-0.64
0.00

-0.31
-0.05

The angular response for the Octa is attributed to the configuration of the diodes of the
Octa and the surrounding materials that causes perturbation to incident radiation. For
more optimization, Monte Carlo simulations can be used to evaluate the angular response
of the Octa. The comparison between the Monte Carlo simulations and the Octa
measurement can improve the design of the Octa. We could not deliver a full treatment
plan to the phantom to correct it by using the correction factors of this work because of
COVID-19 restriction. For future work, we recommend delivering a modified treatment
plan for the cylindrical phantom and measuring the dose with the Octa when corrected by
applying the measured correction factors obtained in this work.

6.4 Conclusion
This study investigated the angular response of the Octa array for 6 MV photons in a
cylindrical phantom when the incident radiation beams are perpendicular to the Octa
plane. The angular response of the Octa at different incidence angles for the central SVs
and for the vertical, horizontal, NWSE sand SWNE array are significantly different from
each other between 0° and 180° incidence angles. The maximum reduction in the angular
response for the nine central pixels and for all the arrays of the Octa is at 90° as shown in
Figures 47- 50. There was no significant difference in the angular response for the field
sizes of 10 x 10 cm2 or 2 x 2 cm2 or 1 x 1 cm2 where the P-value were 0.9991 and 0.9998,
respectively. There was a good agreement between the GEANT4 simulation and the
experimental results for the angular response of the Octa. The angular response at 90°
incident angle needs more investigation for different field sizes. The angular response
correction factors of 10 x 10 cm2 large field size can improve the beam profiles for the 1
x 1 cm2 and 2 x 2 cm2 small fields at different incidence angles. These correction factors
improved the FWHM and the (20%-80%) penumbra width measurements to within 8%

96

and 1.5 mm, and within 2% and 1.4 mm for field sizes 1 x 1 cm2 and 2 x 2 cm2,
respectively. The pixels configuration affects the Octa measurements at some critical
angles, which leads to the angular response of the Octa dosimeter. This study can support
the suggestion to use the square field size 10 x 10 cm2 correction factors to correct the
angular response of the Octa at different angles for VMAT and IMRT. These latter
therapies used these small fields to deliver maximum doses to tumours and could use the
Octa as an important dosimeter for QA testing for these advanced external radiotherapy
techniques.
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Chapter 7 – The angular dependence of the Octa in a custommade phantom designed for quality assurance of stereotactic
body radiation therapy for vertebral metastases
This chapter explores the angular dependent sensitivity of the Octa inside a custom-made
phantom poly-methyl-methacrylate (PMMA) spine. The phantom was custom-made for
measurements relevant to ensure the quality of stereotactic body radiation therapy
(SBRT) for vertebral metastases.

7.1 Introduction
In chapter 6 it was demonstrated that, when the Octa was parallel to the treatment couch
and the linac gantry rotates between 0 and 360 degrees, the sensitivity of the Octa to
incident radiation is minimized when the array parallel to incident radiation (i.e at gantry
angles 90° and 270°). The Octa in the custom-made phantom fabricated in chapter 5 is
perpendicular to the treatment couch, and as the linac gantry rotates between 0 and 360
degrees, the Octa is always 90 degrees with respect to incident radiation (i.e. beam central
axis is along of the Octa plane).
The aim of this chapter was to investigate the angular response of the Octa inside the
custom-made phantom fabricated in chapter 5 and calculate the correction factors to
compensate for that dependence.

7.2 Methodology
The custom-made phantom was imaged with the Octa and without the Octa (Figure 53)
by using a Siemens Somatom 64 slice computed tomography (CT), using a slice thickness
of 2 mm at the Illawarra Cancer Care Centre ICCC (Wollongong Hospital, NSW,
Australia). CT images were transferred to a commercial treatment planning system (TPS),
Pinnacle3 V16; (Philips Medical Systems) and a collapsed cone convolution algorithm
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was used for dose calculations. A comparison was made between calculations on the CT
scan of the phantom with the Octa and those on the CT scan of the phantom without the
Octa.

(a)

(b)

Figure 53. (a) The custom-made phantom with the Octa and (b) image of treatment planning
for the phantom.

Doses calculations with the TPS were exported into a Microsoft “Excel” spreadsheet as
shown in Figure 54 for a specific gantry angle (gantry 0). The beam profiles for all arrays
of the Octa were extracted from these data by identifying the position of the Octa in the
beam maps. The central pixels of the Octa were placed in the isocentre of the radiation
beam.

Figure 54. Dose map of custom-made phantom calculated by TPS. Displayed as a colour-coded “Excel”
spreadsheet.
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First, for the Octa response calibration, the radiation beams were targeted perpendicular
on the Octa inside the phantom were programmed to distribute the dose equally by using
field size 10 x 10 cm2, 100 MU, SSD 95 cm and photon energy 6 MV at depth of 5 cm as
in Figure 55. Then, the benchmark for the Octa response was achieved by the calculating
the dose (Gy) from TPS and the Octa charges (in nC).

Figure 55. Calibration of the Octa dosimeter in the PMMA spine phantom

The irradiation beams for the angular dependence study were produced with a photon
energy of 6 MV with a flattening filter (FF) or flattening filter free (FFF) at various angles.
For 6 MV FF (dose rate 600 MU/min), the phantom was irradiated from 0°-360° beam
incidence angle, in steps of 10° delivered with a field size of 10 x 10 cm2, 100 MU. For
photon energy 6 MV FFF (dose rate 1400 MU/min), the spine phantom irradiated with
100 MU, field size 10 x 10 cm2 and SSD 95 cm at angles from 0° to 360° in steps of 45°
(Figure 56). The photon beams were produced by a TrueBeam (Varian Medical Systems)
medical accelerator (linac). The angular response correction factors were calculated by
using the equations (6.1, 6.2 and 6.3) and the experiments were conducted at St George
Hospital (Kogarah, NSW, Australia).
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Figure 56. The incident beams angles for irradiating the PMMA spine phantom to

calculate its angular response.
For small field dosimetry, the angular correction factors of the Octa for large field for
photon energy 6 MV FFF were applied to correct the small field 1 x 1 cm2 100 MU 6 MV
FFF at angles from 0° to 360° in steps of 45°.
For spinal cord pre-treatment QA applications, the PMMA spine phantom and the Octa
dosimeter are used at the dose level that will be delivered to the patient. VMAT 6 MV
FFF plans are used to treat small lesion in a spinal cord surrounded by critical structures.
The verification procedure includes the patient plan delivery calculated by the TPS to the
QA spine phantom and then measuring the dose by using the Octa dosimeter to compare
the calculated and measured dose.

7.3 Results and discussion
The Octa dosimeter has insignificant effect on the homogeneous PMMA spine phantom.
The dose was calculated by using the TPS which extracted for the average of the nine
central pixels of the Octa (Figure 57) and the measured dose by using the Octa inside the
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PMMA spine phantom at different angles for photon energy 6 MV FF ( Figure 58). For
the measured dose by the Octa, five pixels of the vertical array were chosen to measure
the doses at these pixels. Pixel#2 located close to the beginning of the array; pixel#128
located close to the ending of the array; pixels #64, 65, 66 are in the centre of the array.

Figure 57. The dose measured as a function of radiation incident beams angles from 0° to 360°
in steps 10° for photon energy 6MV FF and field size 10 x 10 cm2 from the central nine pixels
which are extracted from the TPS.
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Figure 58. The dose measured as a function of radiation incident beams angles from 0° to 360°
in steps 10° for photon energy 6MV FF and field size 10 x 10 cm2 from the five pixels of the
Vertical array of the Octa (pixel#2 located close to the beginning of the array; pixel#128 located
close to the end of the array; pixels#66, 65, 64 located in the middle of the array).

In the Figure 57, the dose calculated dose by the TPS for the central pixels are a slightly
increased from 0° angle to 90° angle, then the dose slightly decreases at 110° angle then
drops sharp from 120°-140°. After 140° a slight increase until it reaches a central
maximum at 180° angle. The maximum calculated dose is attained at 90° (or 270°) angle
where the incident radiation beams have lower attenuation from the phantom. Figure 58
is the actual Octa response and is of course very similar in shape to the TPS target dose
profile. For the measured dose by the Octa (Figure 58), the overall response is similar to
the TPS response, but the maximum response is found at 100° angle and is lower than
expected, attributed to a misalignment of the isocentre of the radiation beam with respect
to the centre of the Octa. This increase and decreases in the dose profile are attributed to
the phantom shape in addition to the assembly materials of the dosimeter. From 0° beam
incidence angle to 90° angle the phantom entry surface is curved, then from 90° angle to
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140° the beam enters through the flat lower surface of the phantom at 140° angle the
phantom lower corner and the dosimeter edge are in the beam path and the patient couch
also starts to intrude at this angle where there would be the maximum attenuation for the
photon beams. At 180° beam incidence angle, the couch and PCB lie directly in the path
of the incident radiation beams before reaching the SVs of the Octa so the measured dose
is expected to be lower than at the 0° beam incidence angle.
The response of pixel#2 is opposite to pixel#128 where each of them is lie in the opposite
direction of the incidence beam. When the incident radiation beam is at 0° angle, pixel#2
is higher up and pixe#128 is lower down in the Octa array so pixel#2 has a higher
response than pixel#128. Then, at 90° angle they have near-identical response (since they
are both the same distance from the beam source)while after 90 angle they have opposite
response. At 180° angle, pixel#128 has a higher response than pixel#2 because pixel#128
is closer to the beam source while pixel#2 on the other side of the Octa array.
Furthermore, the calculated dose from the TPS and the measured dose from the Octa were
performance for photon energy 6 MV FFF (see Figure 59 and Figure 60). The phantom
was irradiated with field size 10 x 10 cm2 from 0° to 360° angle in steps of 45°, the
response of the Octa for photon energy 6 MV FFF is similar to the Octa response for
photon energy 6 MV FF. The difference is just the measured and calculated dose for
photon beam 6 MV FFF is lower than the measured and calculated dose for 6 MV FF. In
general, the calculated dose of the TPS was slightly higher than the dose measured by the
Octa. Therefore, the raw Octa readings need to be corrected.
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Figure 59. The dose from TPS for photon energy 6 MV FFF

Figure 60. The dose from the Octa. For photon energy 6MV FFF.#2 line = Pixel #2 dose

reading.#64 line = Pixel#64 dose reading etc.
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As estimated from Figure 57 and Figure 58 , the angular dependence of the Octa inside
the PMMA spine phantom for two arrays of the Octa sampling volumes (the Vertical and
the Horizontal arrays) was calculated (see Figure 61and Figure 62 for photon energy 6
MV FF) for all 129 pixels of each array (the line connected just the chosen pixels).

Figure 61. The angular dependence for all 129 pixels in Vertical array of the Octa for photon
energy 6MV FF.

106

Figure 62. The angular dependence for all 129 pixels in Horizontal array of the Octa for photon
energy 6 MV FF.

The angular response of the Octa’s Vertical and Horizontal arrays as a function of
incidence radiation beams for photon energy 6 MV FF is approximately flat from 0° to
110° angle with a slight climb in the response between 90 and 110 then a slight drop in
response after 110° degree. From 180° to 350°, the angular response is nearly a mirrorimage of the 0° to 180°.
The outcomes of calculating the angular response of the Octa Vertical and Horizontal
arrays in photon beams of 6 MV FFF and 10 x 10 cm2 field size are illustrated in Figure
63 and Figure 64.
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Figure 63.The Octa angular dependence for 129 pixels in Vertical array for photon energy 6MV
FFF.

Figure 64. The Octa angular dependence for 129 pixels in Horizontal array for photon energy 6 MV
FFF.
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The angular response of the Octa array from 0° angle to 90° angle is approximately flat,
then it reduces until reaching its minimum reduction at 180° angle. From 180° angle, the
angular response slightly increases until 360°. Both halves of the phantom are identical,
however, the angular response of Octa array in the second half of the beam incidence
angle range is lower than the first half because of misalignment of the isocentre of the
radiation beam in relation to the centre of the Octa inside the PMMA spine phantom. By
using equation 6.3, the correction factors can be calculated and applied for all the pixels
to correct the Octa readings.
The beam profiles as a function of the irradiation incident beams along the Vertical central
line in the PMMA spine phantom at different incidence angles from 0° to 165° with the
Octa raw and the Octa corrected for 6 MV FF illustrated in Figures 65-76.

Figure 65: The beam incidence profiles of the central vertical line of the PMMA spine phantom
at 0° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses,
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors
for 6MV FF.
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Figure 66: The beam incidence profiles of the central vertical line of the PMMA spine phantom
at 15° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses,
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors
for 6MV FF.

Figure 67: The beam incidence profiles of the central vertical line of the PMMA spine phantom
at 30° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses,
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors
for 6MV FF.
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Figure 68: The beam incidence profiles of the central vertical line of the PMMA spine phantom
at 45° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses,
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors
for 6MV FF.

Figure 69: The beam incidence profiles of the central vertical line of the PMMA spine phantom
at 60° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses,
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors
for 6MV FF.
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Figure 70: The beam incidence profiles of the central vertical line of the PMMA spine phantom
at 75° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses,
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors
for 6MV FF.

Figure 71: The beam incidence profiles of the central vertical line of the PMMA spine phantom
at 90° irradiated incidence angles. The data points in 3 colors show comparison of the TPS doses,
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors
for 6MV FF.
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Figure 72: The beam incidence profiles of the central vertical line of the PMMA spine phantom
at 105° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses,
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors
for 6MV FF.

Figure 73: The beam incidence profiles of the central vertical line of the PMMA spine phantom
at 120° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses,
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors
for 6MV FF.
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Figure 74: The beam incidence profiles of the central vertical line of the PMMA spine phantom
at 135° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses,
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors
for 6MV FF.

Figure 75: The beam incidence profiles of the central vertical line of the PMMA spine phantom
at 150° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses,
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors
for 6MV FF.

114

Figure 76: The beam incidence profiles of the central vertical line of the PMMA spine phantom
at 165° irradiated incidence angle. The data points in 3 colors show comparison of the TPS doses,
Octa raw dose measurements and Octa corrected doses by using the calibrated correction factors
for 6MV FF.

For small dosimetry, the calibration factors for large field 10 x 10 cm2 were used to correct
the Octa readings for small fields of 1 x 1 cm2 for 6 MV FFF. Figures 77-92 show the
changes in the beam profiles of the vertical central line of the Octa inside the PMMA
spine phantom at angles from 0° to 315° in steps of 45°. In addition, the Figures illustrate
the difference between the calculated, measured dose and the corrected dose for the
Horizontal array of the Octa for 1 x 1 cm2 corrected by 10 x 10 cm2 for photon energy 6
MV FFF.
Figures 77 to 92 show slight discrepancies between the “corrected” dose measured by the
Octa and the dose calculated by the TPS. This error attributed to the difference in
calibration between 6MV FFF and 6MV FF beam profiles. Furthermore, there are a shift
in the central maximum position along the distance x-axis because of a slight
misalignment of geometric center of the Octa and the isocenter of the radiation beam
when the Octa was first set up for the measurements.
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Figure 77: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 0°
incidence angles with the Octa measurements and with the Octa corrected measurements
comparing with the TPS of the Octa Vertical array.

Figure 78: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 45°
incidence angles with the Octa measurements and with the Octa corrected measurements
comparing with the TPS of the Octa Vertical array.
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Figure 79: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 90°
incidence angles with the Octa measurements and with the Octa corrected measurements
comparing with the TPS of the Octa Vertical array.

Figure 80: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 135°
incidence angles with the Octa measurements and with the Octa corrected measurements
comparing with the TPS of the Octa Vertical array.
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Figure 81: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 180°
incidence angles with the Octa measurements and with the Octa corrected measurements
comparing with the TPS of the Octa Vertical array.

Figure 82: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 225°
incidence angles with the Octa measurements and with the Octa corrected measurements
comparing with the TPS of the Octa Vertical array.
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Figure 83: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 270°
incidence angles with the Octa measurements and with the Octa corrected measurements
comparing with the TPS of the Octa Vertical array.

Figure 84: The beam profiles for the field size 1 x 1 cm2 for photon energy 6MV FFF at 315°
incidence angles with the Octa measurements and with the Octa corrected measurements
comparing with the TPS of the Octa Vertical array.
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Figure 85: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by
the Octa Horizontal array sensitive volumes for 0° radiation incidence beam.

Figure 86: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by
the Octa Horizontal array sensitive volumes for 45° radiation incidence beam.
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Figure 87: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by
the Octa Horizontal array sensitive volumes for 90° radiation incidence beam.

Figure 88: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by
the Octa Horizontal array sensitive volumes for 135° radiation incidence beam.
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Figure 89: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by
the Octa Horizontal array sensitive volumes for 180° radiation incidence beam.

Figure 90: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by
the Octa Horizontal array sensitive volumes for 225° radiation incidence beam.
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Figure 91: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by
the Octa Horizontal array sensitive volumes for 270° radiation incidence beam.

Figure 92: The beam profiles for a 1 x 1 cm2 field of photon energy 6MV FFF as measured by
the Octa Horizontal array sensitive volumes for 315° radiation incidence beam.
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7.4 Conclusion
The Octa silicon detector with its small SVs diodes was placed to zero angle direction of
the beam in the PMMA spine phantom where the maximum reduction in the angular
response for the Octa as in the chapter 6 (i.e. beam central axis is along of the Octa plane).
Preliminary results in Figures 61, 62, 63 and 64 illustrate that the angular response for
photon energy 6 MV FF and 6 MV FFF is reasonably flat from 0° to 90° incident beam
angle because the phantom is part of the cylinder for 0 - 90 degree angles, and angles in
this range have only a slightly impact on the measurements produced by the Octa. After
90° angle, the angular response reduces until reaching 180° angle where there is a
minimum response. In this position, the couch, and the assembly materials of the Octa
intercept the incident radiation beams. For small field dosimetry, the Octa for photon
energy 6 MV FFF needs to calibrate at 6 MV FFF not 6 MV FF due to difference in the
photon spectrum in place of the Octa.
The investigations confirmed the Octa dosimeter can provide high resolution maps of
dose distribution, with the Vertical and the Horizontal arrays providing 0.3 mm resolution
and the NWSE and SWNE arrays providing 0.43 mm resolution, whereas the TPS data is
provided in 0.7813 mm increments.
The measurements gained in this study showed that the Octa, a 2D monolithic silicondiode array can be used in a PMMA phantom in a vertical position with Octa plane along
the beam to accurately measure the received dose. The Octa provides information about
the dose distribution with small spatial resolution, comparable to the resolution of the
TPS. Therefore, there is potential to use the Octa for machine specific QA and spinal cord
patient QA applications and fully replacing the film.
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Chapter 8 - Conclusions
Globally, half of all cancer patients require radiation therapy. Radiation therapy demands
adequate quality assurance (QA) to ensure the treatment is safe and effective for patients.
The success of QA largely depends on adequate radiation sensors (dosimeters being
available and properly used.
In this thesis, the candidate considered two dosimeters recently designed at the Centre for
Medical Radiation Physics, University of Wollongong, and investigated their applications
in scenarios that offer particular challenges in modern x-rays external-beam radiation
therapy.
The following is a summary of the results of this thesis by reference to the original aims:
Part 1: the MOSkin, design improvement and applications.
Aim1: Optimizing the MOSkin for measurements of dose due to medical imaging.
Chapter 3 describes how the design of the MOSkin, a point dosimeter with 0.07 mm water
equivalent depth of dose measurements as required by ICRU for skin dosimetry, was
improved, to enhance its sensitivity to ionizing radiation. Enhanced sensitivity was
achieved by the changing the thickness of the sensitive volume (the silicon dioxide under
the gate oxide) and tuning the external bias applied on the gate electrode during
irradiation. Chapter 3 also explored the effect of boron implantation dose under the
silicon of the gate electrode.
As anticipated, it was shown that MOSkins with a thicker silicon dioxide had enhanced
sensitivity and a higher initial threshold voltage, which, for a particular maximum Vth
measured by the reader in use, reduce the MOSkin lifespan. The new technological
approach of implanting boron dose under the gate before growing the silicon dioxide
resulted in a decreased initial threshold voltage, essentially extending the MOSkin
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lifespan. In summary, MOSkin sensitivity was determined by the thickness and by the
quality of the silicon dioxide, and the boron implantation did not create instability of the
threshold voltage. The spread-out of MOSkin sensitivity, for MOSkins in the same batch,
was ± 1%. This would allow to prescribe a single sensitivity for all MOSkin fabricated
within the same batch.
Aim 2: Explore the characteristics of a novel eXaSkin bolus radiation therapy using
the MOSkin.
In chapter 4, the candidate used MOSkins was used to evaluate the characteristics of a
novel eXaSkin bolus. First, the candidate investigated the dose build-up produced by the
eXaSkin, for 6 MV photon beams. The surface and build up dose characteristics of
eXaSkin and the percentage surface dose measurements for different oblique incident
beams were investigated by comparison with solid water-equivalent materials.
Measurements were achieved using MOSkin dosimeter and compared with an advanced
Markus chamber. The outcomes of this method revealed that the dmax of eXaSkin at 6 MV
was approximately 0.9 cm. This bolus also displays a higher dose in the build-up region
between 2 and 10 mm depth and a higher dose than solid water-equivalent slabs with
oblique incidence angles beams.
The advanced applications of eXaSkin bolus, an alternative to commercial Superflab
tissue-equivalent bolus, for 6 MV photon-beam radiotherapy were studied. Clinical plan
for head-and-neck were delivered with both static fields and the volumetric modulated
arc therapy (VMAT) technique, to an anthropomorphic phantom in three situations: with
no bolus on the phantom’s surface, with Superflab, and with eXaSkin. In each situation,
the dose to a central planning target volume (PTV) was measured with an ionization
chamber in the nasopharynx region, and the doses to the skin at three locations within the
area of a neck lymph node PTV, were measured with MOSkin silicon dosimeter.
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Measurements were compared to calculations with the treatment planning system (TPS).
The MOSkinTM results under the eXaSkin displayed a good agreement (2 - 6 %) with
calculations for VMAT. Slight disagreements in dose levels were explained by
suboptimal adherence of Superflab to the phantom’s surface as well as difficulties in
accurately reproducing its placement between the imaging and the radiotherapy treatment
time intervals. In all situations, dose measured at the central target agreed to within 1%
with calculations. eXaSkin was shown to have superior adaptation to the phantom’s
surface, creating minimal bubbles or air gaps between the skin surface and bolus,
promoting accurate location and reproducibility of set-up conditions. eXaSkin with its
higher-density material, offers an adequate dose build-up to achieve full skin dose with
less material thickness than Superflab. The outcomes of this study confirmed that
MOSkinTM dosimeter with eXaSkin bolus can provide advanced tools for skin
radiotherapy QA and accurate dose delivery to the skin target, respectively.
Part 2: the Octa and its applications
Aim 3: In stereotactic radiation therapy for vertebral metastases, a dosimeter should
measure dose distributions in the horizontal plane, rather than in the coronal plane.
This aim was to design the ‘spine phantom’, a phantom custom-made to
accommodate the Octa in the horizontal plane.
A spine phantom was designed and manufactured in the University of Wollongong
(NSW, Australia) suitable for the Octa dosimeter. The spine phantom was constructed
from polymethyl methacrylate (PMMA) with a density of 1.19g/cm3 and designed to
present cross-section of the spinal cord in horizontal plane. The dimensions of the PMMA
spine phantom with the Octa located it between the components sections were illustrated
in chapter 5. This phantom with the Octa dosimeter in its horizontal plane was used to
measure the distribution dose map in 2-dimensions conveniently and accurately. It was
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the first spine phantom with 2D monolithic dosimeter for real time dosimetry replacing
EBT film currently used for spinal tumours treatment delivery QA
Aim 4: Explore the Octa response as a function of the angle of incidence of radiation
beams, in a standard cylindrical geometry, with the array measuring in the frontal
plane.
Advanced radiotherapy treatments employ small fields to deliver maximum dose to the
target and minimum dose to nearby healthy tissues. The main challenges for the
measurements in small radiation fields that are addressed by code of practice (CoP) are
partial occlusion of the primary source; loss of charged particle equilibrium (influenced
by details of the radiation beams and the materials it is penetrating) and dimensions of
dosimeter with respect to the radiation field (related to type and details of the dosimeter
in use).
The Octa is a 2D silicon array dosimeter with 0.3 mm and 0.43 mm pitch for orthogonal
and diagonal arrays, respectively. To use the Octa for delivered dose verification in small
radiation fields, its angular response was investigated. Chapter 6 displayed the Octa
angular dependence by using 10 x 10 cm2 field size 6MV in a cylindrical phantom and
calculating the correction factors from 0° to 180° steps in 15°. Then, an attempt was made
to apply the correction factors from the large square field response to modify small square
field data. The incident radiation beams were varied in a plane perpendicular to the Octa
plane. The EBT3 films extracted beam profiles for all square field sizes and the Octa
measurements were used to calculate the angular response of the Octa. The correction
factors from the large field 10x10 cm2 were calculated. There was no significant
difference in the angular response between the square field sizes. A good agreement was
recorded between the GEANT4 simulation and the experimental results for angular
response of the Octa for field size 10x10 cm2. The angular response at 90° angle needs
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more investigation for different field sizes. Correction factors were applied to correct the
6MV small square fields. The FWHM and the (20% - 80 %) penumbra measurements
were used to compare between the EBT3 films beam profiles and the Octa readings before
and after the correction. These correction factors improved the FWHM and the (20 %-80
%) penumbra width measurements to within 8 % and 1.5mm, and within 2% and 1.4 mm
for 1x1 cm2 and 2x2 cm2, respectively. The accuracy in data collected by the Octa during
irradiation will provide accuracy in data measured during patient treatments, in turn, the
Octa can be used in QA of advanced radiotherapy as a reference dosimeter.
Aim 5: Explore the Octa response as a function of the angle of incidence of radiation
beams, in the ‘spine phantom’ geometry, with the array measuring in the horizontal
plane.
A new phantom was designed at the CMRP, the spine phantom, to accommodate the Octa
so that it could measure dose distribution in the horizontal plan. The phantom was
fabricated from the PMMA with density 1.19g/cm3. In chapter 7 the candidate has
performed a study of the perturbation effect of the Octa dosimeter in the homogeneous
phantom. The beam profiles were extracted from the TPS and a comparison between the
phantom with and without he Octa was achieved. The results show that the Octa has no
significant influence on the dose perturbation in homogeneous phantom. Preliminary
results for the angular response were calculated for the nine central pixels of the Octa.
Experiments were conducted for 10x10 cm2 6MV FF and 6MV FFF to calculate the
angular response. There are differences in spatial resolution of the Octa along linear arrays
profiles (0.3) and the extracted result from the central TPS (0.7813 mm). In chapter 6, the
minimum angular response was where the Octa plane was at 90° to the incident beam this
is represents 0° angle for the PMMA spine phantom. The length of the path that the
radiation particles must pass through at each angle to reach the Octa sensitive radiation
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volume may be different. The PMMA spine phantom has an arch shape at its top (from
0° to 90° angle whereas from 90° to 180° it has a flat surface. Calculations were done to
determine the correction factors from initial large field measurements. These were used
to modify the raw dose data for small fields for use in advanced radiotherapy treatments.
In this thesis many materials, devices, systems and programs were used as tools to
improve QA program for advanced radiotherapy treatments. Our results show that
MOSkins with eXaSkin bolus can be used as a point silicon dosimeter for skin dosimetry
and could potentially be applied successfully for dosimetry on a body surface or in other
region of high dose gradient in treating other parts of the human body with different types
of modalities of radiation treatments.
The Octa, a 2D dosimeter, when used with the new PMMA spine phantom and cylindrical
phantom was shown to be useful for various radiotherapy QA program. The angular
response of the Octa and spine phantom or Octa and cylindrical phantom systems needs
comprehensive study for determining the intrinsic angular response factors. This was
achieved by arranging the incident radiation beams to be applied at accurately known
angles in a plane parallel to Octa plane in both phantoms by using EBT3 films and
calculating the angular response factors. In addition, by using the spine phantom with
different radiation treatments modalities which include or exclude the spinal cord
treatment in radiotherapeutic spine treatments, it was demonstrated that these devices and
systems are realistic and accurate prospects for a spine radiotherapy QA program. For the
cylindrical phantom, advanced clinical radiotherapy plans were delivered to the Octa to
produces accurate measurements the dose by the Octa corrected appropriately by using
the experimental correction factors. Finally, Monte Carlo simulation verified the results
of the experiments by using same set up and considering the densities of the materials
that were used in the experiments. In addition, the effect of the field size on the angular
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response was measured and used to calculate the small field angular response correction
factors.
The success of the devices and procedures used in the work summarized by this thesis
shows that these devices (MOSkin and Octa) can verify the delivered dose to targets and
thus can be confidently adopted into clinical practice. Similarly, the mathematical physics
formulae and protocols applied allow accurately for phenomenological parameter (such
as material densities, dose build-up, path length, angular dependence, and accumulation
of uncertainties) and can therefore be adapted for future QA applications in radiotherapy
as other new dosimeter devices and systems become progressively available.

Future work
Implement in clinical practice the MOSkin as a reliable and accurate dosimeter for routine
real time in vivo skin dosimetry on interfaces and under boluses. For that more
experiments across different radiation oncology to be carried out. New reader with large
range of Vth measurements to be developed to extend life span of the MOSkin.
To implement Octa 2D monolithic dosimeters for machine and patient specific QA to
routine clinical practice. For that implement obtained angular corrections found for
application of the Octa in sagittal plane in a cylindrical and in a transverse plane in a spine
phantom and compare 2D maps predicted by TPS and measured with Octa and EBT film
during the IMRT and VMAT delivery.
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